image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
9820065eda8d5d15b5cfa59ee2ad908759af16238671c9e8f42f052ed98c42c0.png | complex | <table><tr><td></td><td colspan="2">Age group, years</td></tr><tr><td>Demographics</td><td>< 65</td><td>≥65</td></tr><tr><td>Participants, <i>n</i></td><td>9,883</td><td>3,566</td></tr><tr><td>Person-years,</td><td>124,466</td><td>50,269</td></tr><tr><td>Deaths (all causes), <i>n</i></td><td>460</td><td>1,379<... | <table><tr><td></td><td>Age group, years</td></tr><tr><td>Demographics</td><td>< 65</td></tr><tr><td>Participants, n</td><td>9,883</td></tr><tr><td>Person-years,</td><td>124,466</td></tr><tr><td>Deaths (all causes), n</td><td>460</td></tr><tr><td>Deaths (CVD), n (% of all deaths)</td><td>119 (26)</td></tr><tr><td>Mean ... | <table><tr><td>Age group, years</td></tr><tr><td>≥65</td></tr><tr><td>3,566</td></tr><tr><td>50,269</td></tr><tr><td>1,379</td></tr><tr><td>592 (43)</td></tr><tr><td>73.1 (6.1)</td></tr><tr><td>29.0 (3.9)</td></tr><tr><td>95.1 (10.3)</td></tr><tr><td>160.9 (22.3)</td></tr><tr><td>87.7 (12.9)</td></tr><tr><td>2.6 (1.1)<... |
92a1cd8de1330547d0811534dcb39161ce76119ef085e101fb53a9b0057717b8.png | complex | <table><tr><td></td><td colspan="3">History of diagnosed diabetes</td><td>P-value*</td></tr><tr><td></td><td>Overall</td><td>No</td><td>Yes</td><td></td></tr><tr><td>N</td><td>1873</td><td>1587</td><td>286</td><td></td></tr><tr><td>Age (years; mean ± SE)</td><td>73.0 ± 0.14</td><td>73.0 ± 0.15</td><td>73... | <table><tr><td></td><td colspan="3">History of diagnosed diabetes</td></tr><tr><td></td><td>Overall</td><td>No</td><td>Yes</td></tr><tr><td>N</td><td>1873</td><td>1587</td><td>286</td></tr><tr><td>Age (years; mean ± SE)</td><td>73.0 ± 0.14</td><td>73.0 ± 0.15</td><td>73.1 ± 0.36</td></tr><tr><td>Sex (% female)</td><td>... | <table><tr><td>P-value*</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>0.943</td></tr><tr><td>0.973</td></tr><tr><td>0.535</td></tr><tr><td>0.338</td></tr><tr><td>0.454</td></tr><tr><td>Functional status (%)</td></tr><tr><td>< 0.001</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>< 0.001</td></tr><tr><td>< 0... |
2b1018703d0ac4c59832b7632be2138f8d7ce8768efad00ffb94788c3662cd54.png | simple | <table><tr><td></td><td>Masamoto et al. [5]</td><td>Lee et al. [6]</td><td>Matsuda et al. [7]</td><td>Oswal and Agarwal [8]</td><td>Ville et al. [11]</td><td>Ville et al. [11]</td><td>Present case</td></tr><tr><td>Warfarin dose (mg/day)</td><td>3.5</td><td>6–7</td><td>NA</td><td>NA</td><td>3–6</td><td>5R... | <table><tr><td></td><td>Masamoto et al. [5]</td><td>Lee et al. [6]</td><td>Matsuda et al. [7]</td></tr><tr><td>Warfarin dose (mg/day)</td><td>3.5</td><td>6–7</td><td>NA</td></tr><tr><td>Start of warfarin (weeks)</td><td>20</td><td>14</td><td>14</td></tr><tr><td>PT (INR)</td><td>2.7–2.9</td><td>2.2–3.0</td><td>NA</td></... | <table><tr><td>Oswal and Agarwal [8]</td><td>Ville et al. [11]</td><td>Ville et al. [11]</td><td>Present case</td></tr><tr><td>NA</td><td>3–6</td><td>5–6</td><td>3–4.5</td></tr><tr><td>24</td><td>26</td><td>15</td><td>12</td></tr><tr><td>NA</td><td>1.7–2.5</td><td>0.7–1.9</td><td>1.5–2.0</td></tr><tr><td>24</td><td>32<... |
dff4182080e903cd0468b20e263363ae25b95ea273975bc3e45eb8f30c36e274.png | complex | <table><tr><td></td><td>Crude immediate brush material [21]</td><td>2-step ALI [5, 8, 22, 23]</td><td>2-step suspension [2, 3, 24, 25]</td><td>3D-E spheroids [9, 13]</td></tr><tr><td colspan="5">Characteristics</td></tr><tr><td> Sampling of cells</td><td>Nasal brush biopsy</td><td>Nasal brush biopsy</td><td>Removal of ... | <table><tr><td></td><td>Crude immediate brush material [21]</td></tr><tr><td colspan="2">Characteristics</td></tr><tr><td>Sampling of cells</td><td>Nasal brush biopsy</td></tr><tr><td>Anesthesia required</td><td>No</td></tr><tr><td>Preparation steps</td><td>Cell collectionCell dispersion</td></tr><tr><td>Longevity of c... | <table><tr><td>2-step ALI [5, 8, 22, 23]</td><td>2-step suspension [2, 3, 24, 25]</td><td>3D-E spheroids [9, 13]</td></tr><tr><td colspan="3">Characteristics</td></tr><tr><td>Nasal brush biopsy</td><td>Removal of nasal polyp or nasal forceps biopsy</td><td>Removal of nasal polyp/nasal brush biopsy</td></tr><tr><td>No</... |
0b282c74f285f8b64504aa6137c41fc1e7810f7a20618213c7afc4d08e1fc8d3.png | simple | <table><tr><td>Analysis</td><td>Description of measurement of benefits/effects</td><td>Hypothetical example applied to simulation</td></tr><tr><td>Cost minimisation analysis (CMA)</td><td>A comparison of costs when the effects are considered equal in all respects</td><td>Measurement of the simulation education method v... | <table><tr><td>Analysis</td><td>Description of measurement of benefits/effects</td><td>Hypothetical example applied to simulation</td></tr><tr><td>Cost minimisation analysis (CMA)</td><td>A comparison of costs when the effects are considered equal in all respects</td><td>Measurement of the simulation education method v... | <table><tr><td>Analysis</td><td>Description of measurement of benefits/effects</td><td>Hypothetical example applied to simulation</td></tr><tr><td>Cost-effectiveness analysis (CEA)</td><td>Benefits/effects are measured in natural units (e.g. students educated)</td><td>Measurement of the simulation education method resu... |
bbe9aaf176d13f713ba9904e9a6397ad65d6772bce6fae9b0e1b85c92fbe6e33.png | simple | <table><tr><td>nFiles</td><td>Total</td><td><i>gql</i> = 0</td><td><i>gql</i> = 3</td></tr><tr><td>2</td><td>706</td><td>378</td><td>92</td></tr><tr><td>4</td><td>1076</td><td>666</td><td>105</td></tr><tr><td>8</td><td>1708</td><td>1179</td><td>124</td></tr><tr><td>12</td><td>2270</td><td>1659</td><td>137</td></tr></ta... | <table><tr><td>nFiles</td><td>Total</td></tr><tr><td>2</td><td>706</td></tr><tr><td>4</td><td>1076</td></tr><tr><td>8</td><td>1708</td></tr><tr><td>12</td><td>2270</td></tr></table> | <table><tr><td>gql = 0</td><td>gql = 3</td></tr><tr><td>378</td><td>92</td></tr><tr><td>666</td><td>105</td></tr><tr><td>1179</td><td>124</td></tr><tr><td>1659</td><td>137</td></tr></table> |
34635c3952b3d13117b23ce2b5c3bd5efaabe9e0a59c619b4913eeb97c1325db.png | complex | <table><tr><td>Variable</td><td colspan="6">Solutions for the fixed effects using the mixed effect model</td><td>p-value</td></tr><tr><td> </td><td>Intercept</td><td>cos FA</td><td>cos<sup>2</sup>FA</td><td>cos<sup>3</sup>FA</td><td>Flexion/ extension</td><td>Natural/ TKA</td><td>Natural/ TKA</td></tr><tr><td>Quadricep... | <table><tr><td>Variable</td><td colspan="6">Solutions for the fixed effects using the mixed effect model</td><td>p-value</td></tr><tr><td></td><td>Intercept</td><td>cos FA</td><td>cos2FA</td><td>cos3FA</td><td>Flexion/ extension</td><td>Natural/ TKA</td><td>Natural/ TKA</td></tr></table> | <table><tr><td>Quadriceps load</td><td>52.88</td><td>−7.51</td><td>+0.23</td><td>−0.0011</td><td>+118.91</td><td>+3.79</td><td>0.28</td></tr><tr><td>Tibial rotation</td><td>−1.00</td><td>+0.067</td><td>−0.0011</td><td>+4.75e-6</td><td>−0.38</td><td>+2.66</td><td>0.001</td></tr><tr><td>Peak pressure</td><td>0.89</td><td... |
b829f0df27ccf1e8ed67b1002bd922fa1ee02343036b82adb09397076116bd8b.png | simple | <table><tr><td>Preferred strategy</td><td>Patient characteristics</td></tr><tr><td>Invasive</td><td>Recurrent angina or ischaemia at rest or with low-level activities despite intensive medical therapy</td></tr><tr><td></td><td>Elevated cardiac biomarkers (troponin I or T)</td></tr><tr><td></td><td>New or presumably new... | <table><tr><td>Preferred strategy</td><td>Patient characteristics</td></tr><tr><td>Invasive</td><td>Recurrent angina or ischaemia at rest or with low-level activities despite intensive medical therapy</td></tr><tr><td></td><td>Elevated cardiac biomarkers (troponin I or T)</td></tr><tr><td></td><td>New or presumably new... | <table><tr><td>Preferred strategy</td><td>Patient characteristics</td></tr><tr><td>Conservative</td><td>Low-risk score (e.g. TIMI, GRACE)</td></tr><tr><td></td><td>Patient or physician preference in the absence of high-risk features</td></tr></table> |
8585424b33aa4af465be726a8a5225aebb337680a49edc92f94c707b057f3e11.png | complex | <table><tr><td>DemographicCharacteristics</td><td colspan="2">Insured (n = 2080)</td><td colspan="2">Uninsured (n = 2554)</td><td colspan="2">Total (n = 4634)</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td><td></td><td></td></tr... | <table><tr><td>DemographicCharacteristics</td><td colspan="2">Insured (n = 2080)</td><td colspan="2">Uninsured (n = 2554)</td><td colspan="2">Total (n = 4634)</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td><td></td><td></td></tr... | <table><tr><td>istrative</td><td>1</td><td>9</td><td></td><td></td><td>8</td><td>14.42</td></tr><tr><td>Clerk/technician</td><td>591</td><td>28.41</td><td>638</td><td>24.98</td><td>1229</td><td>26.52</td></tr><tr><td>General worker</td><td>1051</td><td>50.53</td><td>1390</td><td>54.42</td><td>2441</td><td>52.68</td></t... |
735f36fe2598ad5614060a44023577ed7871db4b1afc61e7a0d0c2c1813ac2c8.png | complex | <table><tr><td></td><td></td><td></td><td colspan="2">Nurses</td><td colspan="3">Midwives</td><td></td></tr><tr><td>Baseline inputs</td><td>Doctors</td><td>Clinical officers</td><td>registered</td><td>enrolled</td><td>registered</td><td>enrolled</td><td>direct entry</td><td>Total</td></tr><tr><td colspan="9">Number of ... | <table><tr><td></td><td></td><td></td><td colspan="2">Nurses</td></tr><tr><td>Baseline inputs</td><td>Doctors</td><td>Clinical officers</td><td>registered</td><td>enrolled</td></tr><tr><td colspan="5">Number of staff</td></tr><tr><td>At baseline (2008)1</td><td>806</td><td>1236</td><td>1453</td><td>5134</td></tr><tr><t... | <table><tr><td colspan="3">Midwives</td><td></td></tr><tr><td>registered</td><td>enrolled</td><td>direct entry</td><td>Total</td></tr><tr><td colspan="4">Number of staff</td></tr><tr><td>339</td><td>1711</td><td>0</td><td>10 679</td></tr><tr><td colspan="3">4751</td><td>24 319</td></tr><tr><td colspan="4">Inflow from t... |
4acd2668982cdbbf7b3104f65754ab4de03544ec77421516a76714ba1a1d6278.png | simple | <table><tr><td>Neural-Network Parameters</td><td>Levenberg-Marquardt</td></tr><tr><td>Number of input parameters</td><td>3</td></tr><tr><td>Number of hidden neurons</td><td>9</td></tr><tr><td>Number of output parameters</td><td>1</td></tr><tr><td>Hidden transfer function</td><td>Sigmoidal</td></tr><tr><td>Output transf... | <table><tr><td>Neural-Network Parameters</td><td>Levenberg-Marquardt</td></tr><tr><td>Number of input parameters</td><td>3</td></tr><tr><td>Number of hidden neurons</td><td>9</td></tr><tr><td>Number of output parameters</td><td>1</td></tr><tr><td>Hidden transfer function</td><td>Sigmoidal</td></tr></table> | <table><tr><td>Output transfer function</td><td>linear</td></tr><tr><td>Maximum number of epochs</td><td>1000</td></tr><tr><td>Learning rate</td><td>0.01</td></tr><tr><td>Momentum rate</td><td>0.9</td></tr><tr><td>Stopping gradient</td><td>5.5292 × 10−8</td></tr><tr><td>MU (momentum )</td><td>1 × 10−8</td></tr></table> |
4d306060874f65502e7568065dbdf3453e04f189de58ef44982e5fea63a01f46.png | complex | <table><tr><td></td><td>OR (95% CI)</td><td>p</td></tr><tr><td>Age, y</td><td>1 (0.96,1.05)</td><td>.926</td></tr><tr><td colspan="3">Gender</td></tr><tr><td>Female</td><td>1</td><td></td></tr><tr><td>Male</td><td>0.3 (0.08,1.15)</td><td>.079</td></tr><tr><td>BMI, kg/m<sup>2</sup></td><td>1.22 (0.99,1.49)</td><td>.056<... | <table><tr><td></td><td>OR (95% CI)</td><td>p</td></tr><tr><td>Age, y</td><td>1 (0.96,1.05)</td><td>.926</td></tr><tr><td colspan="3">Gender</td></tr><tr><td>Female</td><td>1</td><td></td></tr><tr><td>Male</td><td>0.3 (0.08,1.15)</td><td>.079</td></tr><tr><td>BMI, kg/m2</td><td>1.22 (0.99,1.49)</td><td>.056</td></tr><t... | <table><tr><td></td><td>OR (95% CI)</td><td>p</td></tr><tr><td>Light smokers</td><td>0.63 (0.12,3.3)</td><td>.589</td></tr><tr><td>Severe smokers</td><td>0.29 (0.05,1.57)</td><td>.150</td></tr><tr><td>Osteoporosis</td><td>NA</td><td></td></tr><tr><td colspan="3">Lumbar lordosis,</td></tr><tr><td><50</td><td>1</td><td><... |
4d7a0b3f6365e9ab854d9f7a36b7f1699065b4be3acec86d74393e2eebca0ee0.png | complex | <table><tr><td>Variables</td><td>Cases/Controls</td><td colspan="4">Genotypes (Cases/Controls)</td><td><i>p</i><sup>a</sup></td><td>OR (95% CI) <sup>a</sup></td></tr><tr><td></td><td></td><td colspan="2">AA/AG</td><td colspan="2">GG</td><td></td><td></td></tr><tr><td></td><td></td><td><i>n</i></td><td>%</td><td><i>n</i... | <table><tr><td>Variables</td><td>Cases/Controls</td><td colspan="4">Genotypes (Cases/Controls)</td><td>pa</td><td>OR (95% CI) a</td></tr><tr><td></td><td></td><td colspan="2">AA/AG</td><td colspan="2">GG</td><td></td><td></td></tr><tr><td></td><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td></td><td></td></tr><tr>... | <table><tr><td>Exposure years</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><27</td><td>268/261</td><td>236/216</td><td>88.1/82.8</td><td>32/45</td><td>11.9/17.2</td><td>0.060</td><td>0.62 (0.38–1.02)</td></tr><tr><td>≥27</td><td>422/414</td><td>374/356</td><td>88.6/86.0</td><td>48/58<... |
4176f9824032af7a8bec747f64d7b5ef53381d41b0ef4eaadc01fb91004ec2b8.png | simple | <table><tr><td></td><td>Intervention</td><td>Control</td><td></td></tr><tr><td>(n, first year)</td><td>(n = 343)</td><td>(n = 350)</td><td></td></tr><tr><td>(n, second year)</td><td>(n = 330)</td><td>(n = 241)</td><td>P <sup>(2)</sup></td></tr><tr><td>(n, both years)</td><td>(n = 673)</td><td>(n = 591)</td><td></td></t... | <table><tr><td></td><td>Intervention</td><td>Control</td><td></td></tr><tr><td>(n, first year)</td><td>(n = 343)</td><td>(n = 350)</td><td></td></tr></table> | <table><tr><td>(n, second year)</td><td>(n = 330)</td><td>(n = 241)</td><td>P (2)</td></tr><tr><td>(n, both years)</td><td>(n = 673)</td><td>(n = 591)</td><td></td></tr><tr><td>Received the study leaflet</td><td></td><td></td><td></td></tr><tr><td>First year</td><td>37.0</td><td>20.0</td><td>0.005</td></tr><tr><td>Seco... |
7a17a7e5b8c4d3ce01817c7401210f2531f4aa2bd948666a1d8c5035086a9f0f.png | complex | <table><tr><td>Strain</td><td>Carbon source (50 g/L)</td><td>Consumed carbon source (g/L)</td><td>2,3-Butanediol (g/L)</td><td>Lactate (g/L)</td><td>Acetate (g/L)</td><td>Acetoin (g/L)</td><td>Ethanol (g/L)</td><td>Biomass (g/L)</td><td>2,3-Butanediol yield (g/g)</td></tr><tr><td rowspan="5">KG1</td><td>Glucose</td><td... | <table><tr><td>Strain</td><td>Carbon source (50 g/L)</td><td>Consumed carbon source (g/L)</td><td>2,3-Butanediol (g/L)</td><td>Lactate (g/L)</td><td>Acetate (g/L)</td><td>Acetoin (g/L)</td><td>Ethanol (g/L)</td><td>Biomass (g/L)</td><td>2,3-Butanediol yield (g/g)</td></tr><tr><td rowspan="4">KG1</td><td>Glucose</td><td... | <table><tr><td>Strain</td><td>Carbon source (50 g/L)</td><td>Consumed carbon source (g/L)</td><td>2,3-Butanediol (g/L)</td><td>Lactate (g/L)</td><td>Acetate (g/L)</td><td>Acetoin (g/L)</td><td>Ethanol (g/L)</td><td>Biomass (g/L)</td><td>2,3-Butanediol yield (g/g)</td></tr><tr><td>KG1</td><td>Maltose</td><td>49.20 ± 0.5... |
9d72954e7a027e1b8efd2f20cc8a52f4067f723ccb768001d2c4ad96a3a0ca24.png | simple | <table><tr><td>Intake</td><td>All dysphagic patients (<i>N</i> = 120)</td><td>Spinal onset dysphagic patients (<i>N</i> = 64)</td><td>Bulbar onset dysphagic patients (<i>N</i> = 56)</td><td><i>p</i></td></tr><tr><td>Normal</td><td>8 (7)</td><td>7 (11)</td><td>1 (2)</td><td>ns</td></tr><tr><td>Postural</td><td>31 (26)</... | <table><tr><td>Intake</td><td>All dysphagic patients (N = 120)</td><td>Spinal onset dysphagic patients (N = 64)</td><td>Bulbar onset dysphagic patients (N = 56)</td><td>p</td></tr><tr><td>Normal</td><td>8 (7)</td><td>7 (11)</td><td>1 (2)</td><td>ns</td></tr><tr><td>Postural</td><td>31 (26)</td><td>20 (31)</td><td>11 (2... | <table><tr><td>Intake</td><td>All dysphagic patients (N = 120)</td><td>Spinal onset dysphagic patients (N = 64)</td><td>Bulbar onset dysphagic patients (N = 56)</td><td>p</td></tr><tr><td>Percutaneous endoscopic gastrostomy</td><td>25 (20)</td><td>3 (5)</td><td>22 (39)</td><td>0.0001</td></tr></table> |
7a0fc322eebcd1dcc85806766694baa6fd547f790659a5532093757a1bdcb797.png | simple | <table><tr><td> Frequency (%) questions</td><td>Most often</td><td>sometimes</td><td>Not often</td><td>never</td><td>No answer</td></tr><tr><td>How often are you giving oral health education to school (nurseries) children?</td><td>48 (19.7)</td><td>70 (44.6)</td><td>19 (12.1)</td><td>20 (12.7)</td><td>—</td></tr>... | <table><tr><td>Frequency (%) questions</td><td>Most often</td><td>sometimes</td><td>Not often</td><td>never</td><td>No answer</td></tr><tr><td>How often are you giving oral health education to school (nurseries) children?</td><td>48 (19.7)</td><td>70 (44.6)</td><td>19 (12.1)</td><td>20 (12.7)</td><td>—</td></tr><tr><td... | <table><tr><td>Frequency (%) questions</td><td>Most often</td><td>sometimes</td><td>Not often</td></tr><tr><td>ealth?</td><td>)</td><td>7)</td><td>—</td></tr><tr><td>Do you know about the water fluoride content of your area?</td><td>26 (16.6)</td><td>107 (68.1)</td><td>24 (15.3)</td></tr><tr><td>Do you have any informa... |
62ba7190502bb253183aee959b1a85279f46b1816ef4573a72c302484255684d.png | simple | <table><tr><td>Type of study</td><td>Scale of analysis</td><td>Data sources</td><td>Interviewee profiles</td><td>No. of interviewees</td></tr><tr><td>History of free care</td><td>National</td><td>Scientific literature, administrative archives and print media, in-depth semi-structured interviews</td><td>Health, agricult... | <table><tr><td>Type of study</td><td>Scale of analysis</td><td>Data sources</td><td>Interviewee profiles</td><td>No. of interviewees</td></tr><tr><td></td><td>Nati</td><td>Scientific literature, administrative archives</td><td>Health, agriculture and education </td><td>n =</td></tr></table> | <table><tr><td>Type of study</td><td>Scale of analysis</td><td>Data sources</td><td>Interviewee profiles</td><td>No. of interviewees</td></tr><tr><td>History of free care</td><td>onal</td><td> and print media, in-depth semi-structured interviews</td><td>(decision-makers, technicians, implementers)</td><td> 28</td></tr>... |
9ce1535b5d1f1e50aaddc6822eff7279f87618be9d0a93aeb7ed1cab085a1a82.png | simple | <table><tr><td></td><td>Raw data</td><td></td><td>Clean data</td></tr><tr><td>Number of reads</td><td>300,582</td><td></td><td>23,498</td></tr><tr><td>Number of nucleotides (bp)</td><td>673,594,247</td><td></td><td>20,685,462</td></tr><tr><td>Longest read length (bp)</td><td>11,914</td><td></td><td>2,261</td></tr><tr><... | <table><tr><td></td><td>Raw data</td><td></td><td>Clean data</td></tr><tr><td>Number of reads</td><td>300,582</td><td></td><td>23,498</td></tr></table> | <table><tr><td>Number of nucleotides (bp)</td><td>673,594,247</td><td></td><td>20,685,462</td></tr><tr><td>Longest read length (bp)</td><td>11,914</td><td></td><td>2,261</td></tr><tr><td>Mean read length (bp)</td><td>2,241</td><td></td><td>880</td></tr><tr><td>Genome coverage %</td><td></td><td>100%</td><td></td></tr><... |
5eb8372b0f377eea31653f6ddac26fa31f525cda9f2db5cbf5359515c6081aa5.png | simple | <table><tr><td>Apicomplexan species </td><td>Positive training set </td><td>Negative training set </td></tr><tr><td><i>B. bovis </i></td><td>18 </td><td>30 </td></tr><tr><td><i>B. microti </i></td><td>23 </td><td>22 </td></tr><tr><td><i>C. hominis </i></td><td>1 </td><td>28 </td></tr><tr><td><i>C. muris </i></td><td>0 ... | <table><tr><td>Apicomplexan species</td><td>Positive training set</td><td>Negative training set</td></tr></table> | <table><tr><td>B. bovis</td><td>18</td><td>30</td></tr><tr><td>B. microti</td><td>23</td><td>22</td></tr><tr><td>C. hominis</td><td>1</td><td>28</td></tr><tr><td>C. muris</td><td>0</td><td>34</td></tr><tr><td>C. parvum</td><td>2</td><td>33</td></tr><tr><td>E. tenella</td><td>30</td><td>143</td></tr><tr><td>N. caninum</... |
99b65e141ee1931e09fe73a54a1412f21e70d01cf5bc27fef16b3df63b04fecc.png | simple | <table><tr><td>Variables</td><td>N</td><td>Pre-intervention</td><td>Post intervention</td><td>p-value</td></tr><tr><td>TUG (sec)</td><td>37</td><td>9.35 (7.16;12.62)</td><td>8.34 (6.27;11.12)</td><td><0.01</td></tr><tr><td>FTSST (sec)</td><td>37</td><td>16.61 (12.50;20.18)</td><td>12.94 (10.07;15.82)</td><td><0.0... | <table><tr><td>Variables</td><td>N</td><td>Pre-intervention</td><td>Post intervention</td><td>p-value</td></tr><tr><td>TUG (sec)</td><td>37</td><td>9.35 (7.16;12.62)</td><td>8.34 (6.27;11.12)</td><td><0.01</td></tr></table> | <table><tr><td>Variables</td><td>N</td><td>Pre-intervention</td><td>Post intervention</td><td>p-value</td></tr><tr><td>FTSST (sec)</td><td>37</td><td>16.61 (12.50;20.18)</td><td>12.94 (10.07;15.82)</td><td><0.01</td></tr><tr><td>Total CCQ score</td><td>37</td><td>3.6 (3.2;4.3)</td><td>3.3 (2.5;3.6)</td><td>0.039</td></... |
6696bfce8f8f371ac6401c4c51ae2a32b4aed39d3577428def710ae6d2f58169.png | complex | <table><tr><td rowspan="2">Compound</td><td rowspan="2">Spiked concentration (<i>μ</i>g/mL)</td><td colspan="2">Intraday </td><td colspan="2">Interday </td></tr><tr><td>Detected concentration (<i>μ</i>g/mL)</td><td>RSD<sup>a</sup> (%)</td><td>Detected concentration (<i>μ</i>g/mL)</td><td>RSD (%)</td></tr... | <table><tr><td rowspan="2">Compound</td><td rowspan="2">Spiked concentration (μg/mL)</td><td colspan="2">Intraday</td><td colspan="2">Interday</td></tr><tr><td>Detected concentration (μg/mL)</td><td>RSDa (%)</td><td>Detected concentration (μg/mL)</td><td>RSD (%)</td></tr><tr><td rowspan="3">Gallic acid</td><td>5</td><t... | <table><tr><td rowspan="2">Compound</td><td rowspan="2">Spiked concentration (μg/mL)</td><td colspan="2">Intraday</td><td colspan="2">Interday</td></tr><tr><td>Detected concentration (μg/mL)</td><td>RSDa (%)</td><td>Detected concentration (μg/mL)</td><td>RSD (%)</td></tr><tr><td rowspan="3">Eugenol</td><td>10</td><td>1... |
3c46bbc6b0140e7d4e2eeaab89181c5eebba8044c03338b80eb9c75159a8a35f.png | complex | <table><tr><td> </td><td>With hardiness n (%)</td><td>No hardiness n (%)</td><td>Total</td><td><i>p </i>value</td></tr><tr><td>With burnout,</td><td>40</td><td>101</td><td>141</td><td rowspan="2"> </td></tr><tr><td>n (%)</td><td>(7.02%)</td><td>(17.72%)</td><td>(24.74%)</td></tr><tr><td>No burnout,</td><td><i>85</i></t... | <table><tr><td></td><td>With hardiness n (%)</td><td>No hardiness n (%)</td></tr><tr><td>With burnout,</td><td>40</td><td>101</td></tr><tr><td>n (%)</td><td>(7.02%)</td><td>(17.72%)</td></tr><tr><td>No burnout,</td><td>85</td><td>344</td></tr><tr><td>n (%)</td><td>(14.91%)</td><td>(60.35%)</td></tr><tr><td>Total,</td><... | <table><tr><td>Total</td><td>p value</td></tr><tr><td>141</td><td rowspan="2"></td></tr><tr><td>(24.74%)</td></tr><tr><td>429</td><td rowspan="2"></td></tr><tr><td>(75.26%)</td></tr><tr><td>570</td><td rowspan="2">0.033</td></tr><tr><td>(100.00%)</td></tr></table> |
6d2bca1261ec90e5e7b4c360394f1dbe2cfd81209641856565743a966a20e6cc.png | complex | <table><tr><td></td><td colspan="2">Naïve</td><td colspan="2">GBT</td></tr><tr><td></td><td>Train Acc</td><td>Test Acc</td><td>Train Acc</td><td>Test Acc</td></tr><tr><td>AP</td><td>97.56 (0.70)</td><td>96.00 (5.62)</td><td>97.56 (0.70)</td><td>96.00 (5.62)</td></tr><tr><td>OVR</td><td>97.85 (0.82)</td><td>96.67 ... | <table><tr><td></td><td colspan="2">Naïve</td><td colspan="2">GBT</td></tr><tr><td></td><td>Train Acc</td><td>Test Acc</td><td>Train Acc</td><td>Test Acc</td></tr></table> | <table><tr><td>AP</td><td>97.56 (0.70)</td><td>96.00 (5.62)</td><td>97.56 (0.70)</td><td>96.00 (5.62)</td></tr><tr><td>OVR</td><td>97.85 (0.82)</td><td>96.67 (5.67)</td><td>97.85 (0.82)</td><td>96.67 (5.67)</td></tr><tr><td>Dense</td><td>67.56 (2.88)</td><td>68.00 (16.27)</td><td>97.70 (0.74)</td><td>96.00 (6.44)</td><... |
89f2eaff48d48a3d2b8f8b35f56097f2e957064d8cd62e30a71e8417f13e6ae4.png | complex | <table><tr><td>Total</td><td>High-Blimp-1</td><td>Low-Blimp-1</td><td><i>P</i> value</td></tr><tr><td>(<i>n</i> = 24)</td><td>(<i>n</i> = 13)</td><td>(<i>n</i> = 11)</td><td></td></tr><tr><td colspan="4">Age, years</td></tr><tr><td> Median</td><td>61</td><td>59</td><td>0.797</td></tr><tr><td> Range</td><td>23–75<... | <table><tr><td>Total</td><td>High-Blimp-1</td><td>Low-Blimp-1</td></tr><tr><td>(n = 24)</td><td>(n = 13)</td><td>(n = 11)</td></tr><tr><td colspan="3">Age, years</td></tr><tr><td>Median</td><td>61</td><td>59</td></tr><tr><td>Range</td><td>23–75</td><td>24–77</td></tr><tr><td colspan="3">Gender</td></tr><tr><td>Male</td... | <table><tr><td>P value</td></tr><tr><td></td></tr><tr><td>Age, years</td></tr><tr><td>0.797</td></tr><tr><td></td></tr><tr><td>Gender</td></tr><tr><td>0.628</td></tr><tr><td></td></tr><tr><td>WBC, × 109/l</td></tr><tr><td>0.033</td></tr><tr><td></td></tr><tr><td>PB blast, %</td></tr><tr><td>0.721</td></tr><tr><td></td>... |
7d6812b8726f015ac0ebb18f59941c1bc8ce2e83f503690ac2f6dc879aa02e60.png | complex | <table><tr><td></td><td colspan="2">MZ twins(n = 126; 63 twin pairs)</td><td colspan="2">DZ twins(n = 76; 38 twin pairs)</td></tr><tr><td></td><td>r value</td><td>95% CI</td><td>r value</td><td>95% CI</td></tr><tr><td>Weight</td><td>0.881</td><td>0.800-0.931</td><td>0.437</td><td>0.077-0.737</td></tr><tr><td>Waist circ... | <table><tr><td></td><td colspan="2">MZ twins(n = 126; 63 twin pairs)</td><td colspan="2">DZ twins(n = 76; 38 twin pairs)</td></tr><tr><td></td><td>r value</td><td>95% CI</td><td>r value</td><td>95% CI</td></tr><tr><td>Weight</td><td>0.881</td><td>0.800-0.931</td><td>0.437</td><td>0.077-0.737</td></tr><tr><td>Waist circ... | <table><tr><td>Serum HDL-cholesterol</td><td>0.840</td><td>0.626-0.895</td><td>0.658</td><td>-0.293-0.798</td></tr><tr><td>Serum triglycerides</td><td>0.527</td><td>0.281-0.707</td><td>0.349</td><td>-0.023-0.625</td></tr><tr><td>Fasting blood glucose</td><td>0.523</td><td>0.453-0.804</td><td>0.545</td><td>0.068-0.744</... |
9a60a3e64651d8f8d811376cea91408088f4c39809a6c519db3b698a53c086cd.png | complex | <table><tr><td colspan="2">Variable</td><td><i>n</i> or <i>M</i></td><td>% or <i>SD</i></td></tr><tr><td colspan="2">Time Since Loss (months)</td><td>6.25</td><td>2.36</td></tr><tr><td colspan="2">Severity of PGD<sup>a</sup></td><td>23.33</td><td>10.27</td></tr><tr><td colspan="2">Age (years)</td><td>44.30</td><td>16.0... | <table><tr><td colspan="2">Variable</td><td>n or M</td><td>% or SD</td></tr><tr><td colspan="2">Time Since Loss (months)</td><td>6.25</td><td>2.36</td></tr><tr><td colspan="2">Severity of PGDa</td><td>23.33</td><td>10.27</td></tr><tr><td colspan="2">Age (years)</td><td>44.30</td><td>16.07</td></tr><tr><td>Gender</td><t... | <table><tr><td colspan="2">Variable</td><td>n or M</td><td>% or SD</td></tr><tr><td>Cause of Death</td><td>Suicide</td><td>12</td><td>7.0%</td></tr><tr><td></td><td>Accident</td><td>7</td><td>4.1%</td></tr><tr><td></td><td>Illness</td><td>109</td><td>63.7%</td></tr><tr><td></td><td>Natural Sudden</td><td>35</td><td>20.... |
e4443294be67d6b3250fd404d91b451ebbe053dad2e23593e729f82f439f48c5.png | simple | <table><tr><td></td><td></td><td>CEPS</td><td>CEPM</td><td>P value</td><td>CEPS</td><td>CEPM</td><td>P value</td></tr><tr><td>19</td><td></td><td>PPM (82)</td><td>PPM (19)</td><td></td><td>No PPM (19)</td><td>No PPM (11)</td><td></td></tr><tr><td></td><td>PG max (mmHg)</td><td>36,97 ± 12,29</td><td>34,65 ± 7,... | <table><tr><td></td><td></td><td>CEPS</td><td>CEPM</td><td>P value</td><td>CEPS</td><td>CEPM</td><td>P value</td></tr><tr><td>19</td><td></td><td>PPM (82)</td><td>PPM (19)</td><td></td><td>No PPM (19)</td><td>No PPM (11)</td><td></td></tr><tr><td></td><td>PG max (mmHg)</td><td>36,97 ± 12,29</td><td>34,65 ± 7,45</td><td... | <table><tr><td></td><td></td><td>CEPS</td><td>CEPM</td><td>P value</td><td>CEPS</td><td>CEPM</td><td>P value</td></tr><tr><td>25</td><td></td><td>PPM (8)</td><td>PPM (2)</td><td></td><td>No PPM (11)</td><td>No PPM (11)</td><td></td></tr><tr><td></td><td>PG max (mmHg)</td><td>28,25 ± 10,82</td><td>36,00 ± 9,89</td><td>0... |
022659dd13c088e0f7b1448ca36ec97787fb71610ef0febf7d6ed06067275607.png | simple | <table><tr><td>Stage</td><td>Role names</td><td>Questionable</td></tr><tr><td>1</td><td>17 (4.03%)</td><td>0</td></tr><tr><td>2</td><td>230 (54.5%)</td><td>84</td></tr><tr><td>3</td><td>30 (7.11%)</td><td>1</td></tr><tr><td>4</td><td>2 (0.47%)</td><td>1</td></tr><tr><td>5</td><td>11 (2.61%)</td><td>0</td></tr><tr><td>N... | <table><tr><td>Stage</td><td>Role names</td><td>Questionable</td></tr><tr><td>1</td><td>17 (4.03%)</td><td>0</td></tr><tr><td>2</td><td>230 (54.5%)</td><td>84</td></tr></table> | <table><tr><td>3</td><td>30 (7.11%)</td><td>1</td></tr><tr><td>4</td><td>2 (0.47%)</td><td>1</td></tr><tr><td>5</td><td>11 (2.61%)</td><td>0</td></tr><tr><td>No data</td><td>132 (31.28%)</td><td>NA</td></tr></table> |
fd73575c3e8769251b3986ce00df2d8b6e2adc4e03407a3ce9b383af14b1f0d9.png | simple | <table><tr><td>Characteristics</td><td>Total (n = 412)</td><td>Men (n = 198)</td><td>Women (n = 214)</td></tr><tr><td>Total steps per day</td><td>8182.4 ± 3537.1</td><td>8448.4 ± 3379.5</td><td>7934.4 ± 3668.7</td></tr><tr><td>Total energy expenditure (kcal/day)</td><td>624.6 ± 275.1</td><td>722.7 &... | <table><tr><td>Characteristics</td><td>Total (n = 412)</td><td>Men (n = 198)</td><td>Women (n = 214)</td></tr><tr><td>Total steps per day</td><td>8182.4 ± 3537.1</td><td>8448.4 ± 3379.5</td><td>7934.4 ± 3668.7</td></tr><tr><td>Total energy expenditure (kcal/day)</td><td>624.6 ± 275.1</td><td>722.7 ± 298.9*</td><td>531.... | <table><tr><td>Characteristics</td><td>Total (n = 412)</td><td>Men (n = 198)</td><td>Women (n = 214)</td></tr><tr><td>Actical total counts (per day)</td><td>186699.7 ± 104354.9</td><td>203739.6 ± 110309.5ψ</td><td>170724.9 ± 95992.9</td></tr><tr><td>Time in sedentary activity (actical) (min/d)</td><td>1098.1 ± 99.2</td... |
bc4a43b5f684c9dcf7eef9230a1ab4d6ef574a5abc978fd96bd1da419dd8d759.png | simple | <table><tr><td>Paramètres</td><td>ε3 (E3/E3)</td><td>ε4 (E4/E3+ E4/E4)</td></tr><tr><td>Nombre de sujets</td><td>31</td><td>9</td></tr><tr><td>Age (années)</td><td>58±7</td><td>59±7</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>26±5</td><td>30±2*</td></tr><tr><td>TA (mm Hg)</... | <table><tr><td>Paramètres</td><td>ε3 (E3/E3)</td><td>ε4 (E4/E3+ E4/E4)</td></tr><tr><td>Nombre de sujets</td><td>31</td><td>9</td></tr><tr><td>Age (années)</td><td>58±7</td><td>59±7</td></tr><tr><td>BMI (kg/m2)</td><td>26±5</td><td>30±2*</td></tr><tr><td>TA (mm Hg)</td><td>15±3</td><td>14±3</td></tr><tr><td>Cholesté... | <table><tr><td>Paramètres</td><td>ε3 (E3/E3)</td><td>ε4 (E4/E3+ E4/E4)</td></tr><tr><td>Apo B (g/l)</td><td>135±15*</td><td>148±20*</td></tr><tr><td>t.Xt (%)</td><td>17</td><td>20</td></tr><tr><td>MCV (%)</td><td>18</td><td>20</td></tr></table> |
269e358256999b29b6b54f9e0e7f4bbb25527f1bcdd227a572cfe9a0e71630df.png | simple | <table><tr><td>No.</td><td>Hospital Level</td><td>Original Supply</td><td>Optimal Supply at Week 1</td><td>Optimal Supply at Week 2</td><td>Optimal Supply at Week 3</td><td>Optimal Supply at Week 4</td></tr><tr><td>1</td><td>2</td><td>74</td><td>45.5</td><td>48.8</td><td>48.8</td><td>51.6</td></tr><tr><td>2</td><td>2</... | <table><tr><td>No.</td><td>Hospital Level</td><td>Original Supply</td><td>Optimal Supply at Week 1</td><td>Optimal Supply at Week 2</td></tr><tr><td>1</td><td>2</td><td>74</td><td>45.5</td><td>48.8</td></tr><tr><td>2</td><td>2</td><td>79</td><td>44.5</td><td>49.4</td></tr><tr><td>3</td><td>2</td><td>160</td><td>90.0</t... | <table><tr><td>Optimal Supply at Week 3</td><td>Optimal Supply at Week 4</td></tr><tr><td>48.8</td><td>51.6</td></tr><tr><td>48.4</td><td>66.2</td></tr><tr><td>73.9</td><td>111.9</td></tr><tr><td>141.8</td><td>142.2</td></tr><tr><td>160.0</td><td>160.0</td></tr><tr><td>121.5</td><td>61.0</td></tr><tr><td>128.6</td><td>... |
26dbd4f1c66446199d15001bc8872c1c768a4b92e05eb10c0189bffb569ee9a9.png | simple | <table><tr><td>Group</td><td>BWC (g)</td><td>TW (g)</td><td>Testosterone (nmol/L)</td><td>TSC (10<sup>4</sup>)</td><td>MF (per 30 min)</td></tr><tr><td>Normal control</td><td>49 ± 16.26</td><td>3.40 ± 0.48</td><td>6.99 ± 3.09<sup><i>∗</i></sup></td><td>47 ± 05.81</td><td>19 ± 1.02<sup><i>... | <table><tr><td>Group</td><td>BWC (g)</td><td>TW (g)</td><td>Testosterone (nmol/L)</td><td>TSC (104)</td><td>MF (per 30 min)</td></tr><tr><td>Normal control</td><td>49 ± 16.26</td><td>3.40 ± 0.48</td><td>6.99 ± 3.09∗</td><td>47 ± 05.81</td><td>19 ± 1.02∗</td></tr><tr><td>Untreated</td><td>39 ± 16.23</td><td>2.76 ± 0.08<... | <table><tr><td>Group</td><td>BWC (g)</td><td>TW (g)</td><td>Testosterone (nmol/L)</td><td>TSC (104)</td><td>MF (per 30 min)</td></tr><tr><td>O.p (50 mg/kg)</td><td>65 ± 17.47</td><td>3.33 ± 0.20</td><td>2.12 ± 1.54</td><td>53 ± 20.17</td><td>16 ± 3.09</td></tr><tr><td>O.p (250 mg/kg)</td><td>97 ± 12.26∗</td><td>3.62 ± ... |
e3ecb6123b004397c60f1ca1b7733cece3903e69ce3ffec0902f1282cbc2733d.png | complex | <table><tr><td>Outcome</td><td></td><td colspan="2">Rank obtained</td><td colspan="2">Percentage of responders</td><td colspan="7">Priority</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td colspan="3">Post</td><td colspan="3">Pre</td><td>Chi</td></tr><tr><td></td><td></td><td>Post</td><td>Pre</td>... | <table><tr><td>Outcome</td><td></td><td colspan="2">Rank obtained</td><td colspan="2">Percentage of responders</td><td colspan="7">Priority</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td colspan="3">Post</td><td colspan="3">Pre</td><td>Chi</td></tr><tr><td></td><td></td><td>Post</td><td>Pre</td>... | <table><tr><td>Quality of life</td><td>QoL</td><td>2</td><td>4</td><td>91%</td><td>74%</td><td>75%</td><td>6%</td><td>9%</td><td>63%</td><td>21%</td><td>0%</td><td><0.01</td></tr><tr><td>Disability</td><td>Dis</td><td>3</td><td>11</td><td>91%</td><td>63%</td><td>69%</td><td>6%</td><td>16%</td><td>47%</td><td>11%</td><t... |
bffb9341954df00beb2c39fc3d96098a9b41944eeac50b78d2752883b8323e67.png | simple | <table><tr><td> </td><td>Normal controls</td><td>2-kidneys-1-clip model of hypertension</td><td>1-kidney-1-clip model of hypertension</td><td>P</td></tr><tr><td>Heart rate (bpm)</td><td>455.3 ± 60.8</td><td>472.5 ± 54.9</td><td>463.6 ± 55.4</td><td>ns</td></tr><tr><td>Systolic blood pressure - baseline (... | <table><tr><td></td><td>Normal controls</td><td>2-kidneys-1-clip model of hypertension</td><td>1-kidney-1-clip model of hypertension</td><td>P</td></tr><tr><td>Heart rate (bpm)</td><td>455.3 ± 60.8</td><td>472.5 ± 54.9</td><td>463.6 ± 55.4</td><td>ns</td></tr><tr><td>Systolic blood pressure - baseline (mmHg)</td><td>10... | <table><tr><td></td><td>Normal controls</td><td>2-kidneys-1-clip model of hypertension</td><td>1-kidney-1-clip model of hypertension</td><td>P</td></tr><tr><td>Heart rate – after metoprolol (bpm)</td><td>463.0 ± 74.0</td><td>513.8 ± 67.6</td><td>479.3 ± 49.4</td><td>ns</td></tr><tr><td>Systolic blood pressure - after m... |
ef72ca1f2f8f1ca59fe9dd79b0f3afc202d3d9ae05788fc4f962eb2d71a7943f.png | simple | <table><tr><td>GEO</td><td>Tissue type</td><td>Test sample size (n vs. c)</td><td>Sig genes DN</td><td>Reference</td></tr><tr><td>GSE18520</td><td>Ovary</td><td>10 vs. 53</td><td>79</td><td>[66]</td></tr><tr><td>GSE14407</td><td>Ovary</td><td>12 vs. 12</td><td>109</td><td>[67]</td></tr><tr><td>GSE764</td><td>Uterus</td... | <table><tr><td>GEO</td><td>Tissue type</td><td>Test sample size (n vs. c)</td><td>Sig genes DN</td><td>Reference</td></tr><tr><td>GSE18520</td><td>Ovary</td><td>10 vs. 53</td><td>79</td><td>[66]</td></tr></table> | <table><tr><td>GEO</td><td>Tissue type</td><td>Test sample size (n vs. c)</td><td>Sig genes DN</td><td>Reference</td></tr><tr><td>GSE14407</td><td>Ovary</td><td>12 vs. 12</td><td>109</td><td>[67]</td></tr><tr><td>GSE764</td><td>Uterus</td><td>4 vs. 7 benign</td><td>0</td><td>Unpublished</td></tr><tr><td>GSE764</td><td>... |
5ddf90fdb446acce2fa87ac0a9295e6faeac98bb8de07eb1b75f147b0bc32d18.png | simple | <table><tr><td> </td><td>Animals</td><td>−7</td><td>−4</td><td>−1</td><td>+1</td><td>+2</td><td>+3</td><td>+4</td><td>+7</td><td>+8</td><td>+10</td><td>+11</td><td>+14</td></tr><tr><td> </td><td> </td><td>d a.i.</td><td>d a.i.</td><td>h a.i.</td><td>dpi</td><td>dpi</td><td>dpi</td><td>dpi</td><td>dpi<... | <table><tr><td></td><td>Animals</td><td>−7</td><td>−4</td><td>−1</td><td>+1</td><td>+2</td><td>+3</td><td>+4</td><td>+7</td><td>+8</td><td>+10</td><td>+11</td><td>+14</td></tr><tr><td></td><td></td><td>d a.i.</td><td>d a.i.</td><td>h a.i.</td><td>dpi</td><td>dpi</td><td>dpi</td><td>dpi</td><td>dpi</td><td>dpi</td><td>d... | <table><tr><td></td><td>Animals</td><td>−7</td><td>−4</td><td>−1</td><td>+1</td><td>+2</td><td>+3</td><td>+4</td><td>+7</td><td>+8</td><td>+10</td><td>+11</td><td>+14</td></tr><tr><td></td><td>ontrols</td><td>18</td><td> = 18</td><td></td><td></td><td></td><td>= 18</td><td> = 15</td><td>= 12</td><td> 9</td><td>n = 9</t... |
e3db74941da55ca210ba56bf24d16bbe7904535acf98997f6dc843bbc5a4938f.png | complex | <table><tr><td rowspan="3">Variable</td><td>Adopted children (<i>N</i> = 18)</td><td>Parents (<i>N</i> = 26)</td><td rowspan="3"><i>P</i><sup>a</sup></td></tr><tr><td>Mean (SD) [range]</td><td>Mean (SD) [range]</td></tr><tr><td>Age (years)</td><td>14.0 (4.1) [7.9 to 20.0]</td><td>49.0 (5.7) [40.0 to 65.0]</td><td><0... | <table><tr><td rowspan="3">Variable</td><td>Adopted children (N = 18)</td><td>Parents (N = 26)</td></tr><tr><td>Mean (SD) [range]</td><td>Mean (SD) [range]</td></tr><tr><td colspan="2"></td></tr><tr><td>Age (years)</td><td>14.0 (4.1) [7.9 to 20.0]</td><td>49.0 (5.7) [40.0 to 65.0]</td></tr><tr><td>Height (cm)</td><td>1... | <table><tr><td rowspan="3">Pa</td></tr><tr></tr><tr></tr><tr><td><0.001</td></tr><tr><td>0.021</td></tr><tr><td><0.001</td></tr><tr><td><0.001</td></tr><tr><td>n.s.</td></tr><tr><td>n.s.</td></tr><tr><td>0.011</td></tr><tr><td>n.s.</td></tr><tr><td><0.001</td></tr><tr><td>n.s.</td></tr><tr><td>0.015</td></tr><tr><td>0.... |
75d3504fad26205a3447c5896119498b1f6e9ce7191f167f034e2664790bed9c.png | simple | <table><tr><td>Study</td><td>Subject (number)</td><td>Design</td><td>Particles</td><td>Results</td></tr><tr><td>Gong et al [26]</td><td>Healthy volunteers (12)Patients with mild asthma (12)</td><td>Crossover</td><td>Filtered air, Fine CAPS (174 μg/m<sup>3</sup>)</td><td>CAPS induced modest and similar increases in... | <table><tr><td>Study</td><td>Subject (number)</td><td>Design</td></tr><tr><td>Gong et al [26]</td><td>Healthy volunteers (12)Patients with mild asthma (12)</td><td>Crossover</td></tr><tr><td>Gong et al [42]</td><td>Healthy elderly, age (6)Elderly patients with COPD (13)</td><td>Crossover</td></tr><tr><td>Frampton et al... | <table><tr><td>Particles</td><td>Results</td></tr><tr><td>Filtered air, Fine CAPS (174 μg/m3)</td><td>CAPS induced modest and similar increases in parasympathetic stimulation of HRV in both groups</td></tr><tr><td>Filtered air, Fine CAPS (200 μg/m3)</td><td>Decrease in HRV in healthy elderly but not in COPD patients</t... |
d61e0833880a138451b3b7a75f198f6b05cc0c7b5a09883953f2e69949dbd6e1.png | simple | <table><tr><td>Specialty</td><td>No. of clinics</td><td>No. ofpatients</td><td>% of total costrepresented by pharmacy cost(mean ± sd)</td><td>Correlation between costs including and excluding pharmacy costs<sup>1)</sup></td></tr><tr><td>General clinics</td><td>4,695</td><td>3,807,917</td><td>32.04 ± 23.84</td... | <table><tr><td>Specialty</td><td>No. of clinics</td><td>No. ofpatients</td><td>% of total costrepresented by pharmacy cost(mean ± sd)</td><td>Correlation between costs including and excluding pharmacy costs1)</td></tr><tr><td>General </td><td></td><td>3,807,917</td><td>32.04 ± 23</td><td>0.9</td></tr></table> | <table><tr><td>Specialty</td><td>No. of clinics</td><td>No. ofpatients</td><td>% of total costrepresented by pharmacy cost(mean ± sd)</td><td>Correlation between costs including and excluding pharmacy costs1)</td></tr><tr><td>clinics</td><td>4,695</td><td></td><td>.84</td><td>9</td></tr><tr><td>Internal medicine</td><t... |
24a0c8a703fdba21a9b49ac908c320352d2f25a4d5db2d0904add2d8dd7bf285.png | simple | <table><tr><td>EPDnew database</td><td>Source data: type, reference or source repository</td><td># of libraries</td><td>total tags (millions)</td></tr><tr><td><i>H. sapiens</i></td><td>CAGE from ENCODE/RIKEN, downloaded from UCSC genome browser database (12)</td><td>148</td><td>3841</td></tr><tr><td><i>M. musculus</i><... | <table><tr><td>EPDnew database</td><td>Source data: type, reference or source repository</td><td># of libraries</td><td>total tags (millions)</td></tr><tr><td>H. sapiens</td><td>CAGE from ENCODE/RIKEN, downloaded from UCSC genome browser database (12)</td><td>148</td><td>3841</td></tr><tr><td>M. musculus</td><td>CAGE f... | <table><tr><td>ns</td><td>15)</td><td></td><td>6</td></tr></table> |
d2da277d7ca1856427182d89c88c397a2556d11af1fe1053fdc97a811c755c0e.png | complex | <table><tr><td rowspan="2">Socio-demographic factors</td><td rowspan="2"></td><td colspan="2">STHs infection status</td><td rowspan="2">Total</td><td rowspan="2">X<sup>2</sup></td><td rowspan="2">P-value</td></tr><tr><td>Negative</td><td>Positive</td></tr><tr><td rowspan="2">Age</td><td>6–10</td><td>156 (81.7%)</... | <table><tr><td rowspan="2">Socio-demographic factors</td><td rowspan="2"></td><td colspan="2">STHs infection status</td><td rowspan="2">Total</td><td rowspan="2">X2</td><td rowspan="2">P-value</td></tr><tr><td>Negative</td><td>Positive</td></tr><tr><td rowspan="2">Age</td><td>6–10</td><td>156 (81.7%)</td><td>35 (18.3%)... | <table><tr><td>Gender</td><td></td><td>6%)</td><td>.4%)</td><td>0%)</td><td>068</td><td>.031</td></tr><tr><td rowspan="4">Family size</td><td>1 parent and child</td><td>4 (80.0%)</td><td>1 (20.0%)</td><td>5 (100.0%)</td><td rowspan="4">0.03</td><td rowspan="4">0.0</td></tr><tr><td>1 parent and 2 children</td><td>15 (88... |
6bda3ec767de0c97a1a706c073791d0b48b9cf5939a3d1ecd143878ebb31a977.png | simple | <table><tr><td>Putative virus integration-harboring regions<sup>a</sup></td><td>SNPs</td><td>Insertions</td><td>Deletions</td></tr><tr><td>Chr3:140,567,185-140,575,795</td><td>26</td><td>6</td><td>2</td></tr><tr><td>Chr6:33,823,990-33,832,089</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Chr18:102,747-110,847</td><td>... | <table><tr><td>Putative virus integration-harboring regionsa</td><td>SNPs</td><td>Insertions</td><td>Deletions</td></tr><tr><td>Chr3:140,567,185-140,575,795</td><td>26</td><td>6</td><td>2</td></tr></table> | <table><tr><td>Putative virus integration-harboring regionsa</td><td>SNPs</td><td>Insertions</td><td>Deletions</td></tr><tr><td>Chr6:33,823,990-33,832,089</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Chr18:102,747-110,847</td><td>178</td><td>5</td><td>9</td></tr></table> |
2e31636d8afaf6c39b0913819e7964ad4dac829722ac4d2f41aa96c537fc2538.png | complex | <table><tr><td> </td><td>Dependent variable</td><td><i>P</i></td><td>OR</td><td>95% CI</td></tr><tr><td> </td><td>AIH-1</td><td> </td><td> </td><td> </td></tr><tr><td>Model 1</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td rowspan="2"> <i>HLA-DRB1</i><sup><i>∗</i></sup></td><td>Different from 03 and/or 1... | <table><tr><td></td><td>Dependent variable</td><td>P</td><td>OR</td><td>95% CI</td></tr><tr><td></td><td>AIH-1</td><td></td><td></td><td></td></tr><tr><td>Model 1</td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="2">H</td><td>Different from 03 and/or 13</td><td rowspan="2"><0.00</td><td rowspan="2">8.28</td... | <table><tr><td></td><td>Dependent variable</td><td>P</td><td>OR</td><td>95% CI</td></tr><tr><td>LA-DRB1∗</td><td>nd/or 13</td><td>1</td><td></td><td>–19.82</td></tr><tr><td rowspan="2">IL13 rs20541</td><td>AG plus GG</td><td rowspan="2">0.002</td><td rowspan="2">9.45</td><td rowspan="2">2.28–39.18</td></tr><tr><td>AA</... |
4869e04ab4f3327e47f2053206a5d3b6c03e3a8a57dcbb91888f49f3531d338e.png | complex | <table><tr><td>Model</td><td>Insight</td><td>Author, weblink</td></tr><tr><td colspan="3">TECHNIQUES TO STUDY METABOLIC ADAPTATION IN <i>SALMONELLA</i></td></tr><tr><td rowspan="2"><i>S. Typhimurium metabolite profiling for different (nutrient poor, virulence induced) environments and genome-scale metabolite model</i><... | <table><tr><td>Model</td><td>Insight</td><td>Author, weblink</td></tr><tr><td colspan="3">TECHNIQUES TO STUDY METABOLIC ADAPTATION IN SALMONELLA</td></tr><tr><td rowspan="2">S. Typhimurium metabolite profiling for different (nutrient poor, virulence induced) environments and genome-scale metabolite model</td><td rowspa... | <table><tr><td rowspan="2">Deletion effects, e.g., calculations for Δppc</td><td rowspan="2">→ No compensatory flux via the glyoxylate shunt.</td><td>Fong et al., 2013</td></tr><tr><td>PMID: 23432746</td></tr><tr><td>Model</td><td>Result</td><td>Author, weblink</td></tr><tr><td colspan="3">MODELING REGULATION OF SALMON... |
dfb7cd8051746b57bd3d23697e3e59504978a4b7fdca46a6a735d86cf634f8bc.png | simple | <table><tr><td>Booklet themes</td><td>Principal professionala</td></tr><tr><td>Aging</td><td>PT</td></tr><tr><td>Physical activity helps keep you physically fit</td><td>PT</td></tr><tr><td>Food is a prerequisite for health</td><td>PT</td></tr><tr><td>You can take care of problems with your health</td><td>RN</td></tr><t... | <table><tr><td>Booklet themes</td><td>Principal professionala</td></tr><tr><td>Aging</td><td>PT</td></tr><tr><td>Physical activity helps keep you physically fit</td><td>PT</td></tr><tr><td>Food is a prerequisite for health</td><td>PT</td></tr><tr><td>You can take care of problems with your health</td><td>RN</td></tr><t... | <table><tr><td>Booklet themes</td><td>Principal professionala</td></tr><tr><td>Anyone who needs help can get help</td><td>SW</td></tr></table> |
483664cf500676aae342a9c9e1b82ba491ef45a3a03dd87ac2596cd4d18dd64a.png | complex | <table><tr><td>Subgroup</td><td>Group</td><td>No. of AS</td><td>Person-years</td><td>IR</td><td>IRR (95% CI)</td><td><i>P</i> value</td></tr><tr><td colspan="7">By age</td></tr><tr><td rowspan="3"> < 40 years</td><td>Control subjects</td><td>11</td><td>86,359</td><td>12.7</td><td>1 (reference)</td><td></td></tr><tr>... | <table><tr><td>Subgroup</td></tr><tr><td>By age</td></tr><tr><td rowspan="3">< 40 years</td></tr><tr></tr><tr></tr><tr><td rowspan="3">40–59 years</td></tr><tr></tr><tr></tr><tr><td rowspan="3">> 59 years</td></tr><tr></tr><tr></tr><tr><td>By sex</td></tr><tr><td rowspan="3">Male</td></tr><tr></tr><tr></tr><tr><td rows... | <table><tr><td>Group</td><td>No. of AS</td><td>Person-years</td><td>IR</td><td>IRR (95% CI)</td><td>P value</td></tr><tr><td colspan="6">By age</td></tr><tr><td>Control subjects</td><td>11</td><td>86,359</td><td>12.7</td><td>1 (reference)</td><td></td></tr><tr><td>All uveitis</td><td>32</td><td>15,430</td><td>207.4</td... |
152b3161bb50692eba8c94c2f2d0cc435b7ae89d766c968db0b9b955f8f4f033.png | complex | <table><tr><td>Gene name</td><td>Cytoband</td><td>Probeset on U133A array</td><td>No. cases with LOH</td><td>No. cases without LOH</td><td>No. SNPs</td><td>Fold change with LOH</td><td>Fold change without LOH</td><td>T-test</td><td>P-value</td></tr><tr><td colspan="10"><i><underline>Table 4.a.: Genes/probes with CN los... | <table><tr><td>Gene name</td><td>Cytoband</td><td>Probeset on U133A array</td><td>No. cases with LOH</td><td>No. cases without LOH</td><td>No. SNPs</td><td>Fold change with LOH</td><td>Fold change without LOH</td><td>T-test</td><td>P-value</td></tr><tr><td colspan="10">Table 4.a.: Genes/probes with CN loss (CN = 1)</td... | <table><tr><td>CTDSPL</td><td>chr3p21.3</td><td>213597_s_at</td><td>3</td><td>3</td><td>13</td><td>0.997</td><td>0.890</td><td>-5.414</td><td>8.188E-03</td></tr><tr><td>F2R</td><td>chr5q13</td><td>203989_x_at</td><td>3</td><td>2</td><td>4</td><td>6.083</td><td>1.217</td><td>-6.771</td><td>7.275E-03</td></tr><tr><td>RAB... |
a8655651ba0379fb14c08067928ff9e65d815aa1d316e81f8161ae2aff204b64.png | simple | <table><tr><td>Gene symbol/lncRNA</td><td>Degree </td><td>Style </td><td>Type </td></tr><tr><td>Shmt2 </td><td>55 </td><td>Up </td><td>Coding </td></tr><tr><td>NONMMUT069313 </td><td>54 </td><td>Up </td><td>Noncoding</td></tr><tr><td>Vimp</td><td>54 </td><td>Down </td><td>Coding </td></tr><tr><td>NONMMUT068653 </td><td... | <table><tr><td>Gene symbol/lncRNA</td><td>Degree</td><td>Style</td><td>Type</td></tr><tr><td>Shmt2</td><td>55</td><td>Up</td><td>Coding</td></tr><tr><td>NONMMUT069313</td><td>54</td><td>Up</td><td>Noncoding</td></tr><tr><td>Vim</td><td></td><td>D</td><td>Co</td></tr></table> | <table><tr><td>p</td><td>54</td><td>own</td><td>ding</td></tr><tr><td>NONMMUT068653</td><td>54</td><td>Up</td><td>Noncoding</td></tr><tr><td>Asap3</td><td>53</td><td>Up</td><td>Coding</td></tr><tr><td>NONMMUT001721</td><td>53</td><td>Down</td><td>Noncoding</td></tr><tr><td>NONMMUT067923</td><td>53</td><td>Up</td><td>No... |
f4c6268f33a355651aaabe23cd631cb70bbd1a1340f74b9c6c1760bc3665070a.png | complex | <table><tr><td>Variable</td><td>Cases</td><td>Controls</td><td><i>P</i> value</td></tr><tr><td>Age, mean years</td><td>64.21 ± 18.1</td><td>60.74 ± 21.7</td><td>0.198</td></tr><tr><td>Sex</td><td> </td><td> </td><td> </td></tr><tr><td> Male</td><td>41 (47.1%)</td><td>86 (46.7%)</td><td rowspan="2">0.952</td><... | <table><tr><td>Variable</td><td>Cases</td></tr><tr><td>Age, mean years</td><td>64.21 ± 18.1</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>41 (47.1%)</td></tr><tr><td>Female</td><td>46 (59.9%)</td></tr></table> | <table><tr><td>Controls</td><td>P value</td></tr><tr><td>60.74 ± 21.7</td><td>0.198</td></tr><tr><td></td><td></td></tr><tr><td>86 (46.7%)</td><td rowspan="2">0.952</td></tr><tr><td>98 (53.3%)</td></tr></table> |
dd5e65b8db2ee947b239ff7b3b379683271db14994a2b831c89399e8db78d618.png | simple | <table><tr><td>Phage</td><td>Farm</td><td>Genome Size (bp)</td><td>GC Content (%)</td><td>ORFs (<i>n</i>)</td><td>Terminal Repeat (bp)</td><td>Promoters (<i>n</i>)</td><td>Terminators (<i>n</i>)</td><td>Accession Number</td></tr><tr><td>fPS-7</td><td>3</td><td>38,966</td><td>45.6</td><td>51</td><td>200</td><td>12</td><... | <table><tr><td>Phage</td><td>Farm</td><td>Genome Size (bp)</td><td>GC Content (%)</td><td>ORFs (n)</td><td>Terminal Repeat (bp)</td><td>Promoters (n)</td><td>Terminators (n)</td><td>Accession Number</td></tr><tr><td>fPS-7</td><td>3</td><td>38,966</td><td>45.6</td><td>51</td><td>200</td><td>12</td><td>4</td><td>LT961840... | <table><tr><td>Phage</td><td>Farm</td><td>Genome Size (bp)</td><td>GC Content (%)</td><td>ORFs (n)</td><td>Terminal Repeat (bp)</td><td>Promoters (n)</td><td>Terminators (n)</td><td>Accession Number</td></tr><tr><td>fPS-85</td><td>26</td><td>40,429</td><td>45.4</td><td>50</td><td>196</td><td>11</td><td>3</td><td>LT9623... |
37212d3dce43955311b2051946c355555b1129e7bfa2a533f585217d5fee995f.png | complex | <table><tr><td rowspan="2"> </td><td colspan="2">NC</td><td colspan="2">HFD</td></tr><tr><td>Mig-6<sup><i>f/f</i></sup></td><td>Mig-6<sup><i>d/d</i></sup></td><td>Mig-6<sup><i>f/f</i></sup></td><td>Mig-6<sup><i>d/d</i></sup></td></tr><tr><td>Total-cholesterol (mg/dL)</td><td>120.0 ± 7.0</td><td>170.1 ± 18.4<s... | <table><tr><td rowspan="2"></td><td colspan="2">NC</td><td colspan="2">HFD</td></tr><tr><td>Mig-6f/f</td><td>Mig-6d/d</td><td>Mig-6f/f</td><td>Mig-6d/d</td></tr></table> | <table><tr><td>Total-cholesterol (mg/dL)</td><td>120.0 ± 7.0</td><td>170.1 ± 18.4∗</td><td>107.2 ± 11.0</td><td>319.0 ± 25.7∗∗∗###</td></tr><tr><td>HDL-cholesterol (mg/dL)</td><td>86.5 ± 3.1</td><td>133.8 ± 13.7∗∗</td><td>77.4 ± 6.9</td><td>244.6 ± 19.4∗∗∗###</td></tr><tr><td>LDL-cholesterol (mg/dL)</td><td>11.1 ± 1.7<... |
bba85e2db4f2a294c6b1239c22c26d62ea8dd41bfc3bb57ebcb6b03819fd53e7.png | complex | <table><tr><td rowspan="2">Dose scenario</td><td colspan="2">Design</td></tr><tr><td>3 + 3</td><td>CRM</td></tr><tr><td>Scenario 1: (0.00, 0.30, 0.40, 0.60)</td><td>10.1 (3.2)</td><td>12.0 (1.7)</td></tr><tr><td>Scenario 2: (0.05, 0.05, 0.30, 0.30)</td><td>13.3 (3.5)</td><td>11.8 (2.0)</td></tr><tr><td>Scenario 3: (0.0... | <table><tr><td rowspan="2">Dose scenario</td><td colspan="2">Design</td></tr><tr><td>3 + 3</td><td>CRM</td></tr></table> | <table><tr><td>Scenario 1: (0.00, 0.30, 0.40, 0.60)</td><td>10.1 (3.2)</td><td>12.0 (1.7)</td></tr><tr><td>Scenario 2: (0.05, 0.05, 0.30, 0.30)</td><td>13.3 (3.5)</td><td>11.8 (2.0)</td></tr><tr><td>Scenario 3: (0.05, 0.10, 0.15, 0.30)</td><td>14.4 (3.7)</td><td>11.9 (2.2)</td></tr><tr><td>Scenario 4: (0.00, 0.25, 0.30... |
d5f7f99abf7c60f756c38f89d86ffaf214ea9b3c64b3db20ca7c9f1bc050b6d4.png | simple | <table><tr><td>Most prevalent colonizing serotype(s)</td><td>Region</td><td>Reference</td></tr><tr><td>Ia, Ib, II, III, V</td><td>North America, United States, Europe</td><td>Johri et al., 2006; Ippolito et al., 2010; Lamagni et al., 2013; Melin and Efstratiou, 2013; Florindo et al., 2014; Fabbrini et al., 2016</td></t... | <table><tr><td>Most prevalent colonizing serotype(s)</td><td>Region</td><td>Reference</td></tr><tr><td>Ia, Ib, II, III, V</td><td>North America, United States, Europe</td><td>Johri et al., 2006; Ippolito et al., 2010; Lamagni et al., 2013; Melin and Efstratiou, 2013; Florindo et al., 2014; Fabbrini et al., 2016</td></t... | <table><tr><td>Most prevalent colonizing serotype(s)</td><td>Region</td><td>Reference</td></tr><tr><td>V</td><td>t</td><td>t al., 2014</td></tr><tr><td>Ia, VI</td><td>Malaysia</td><td>Karunakaran et al., 2009; Dhanoa et al., 2010</td></tr><tr><td>VI, VIII</td><td>Japan</td><td>Lachenauer et al., 1999; Matsubara et al.,... |
a096b95aeb545802b1424edfb8e1d632221da20ce4c82547d3f5c481464a0501.png | simple | <table><tr><td>Variable</td><td>Dubti</td><td></td><td></td><td>Amibara</td><td></td><td></td><td></td></tr><tr><td></td><td>Female (%)</td><td>Male (%)</td><td>Total (%)</td><td>Female (%)</td><td>male (%)</td><td>Total (%)</td><td>Total (%)</td></tr><tr><td>TBL is a health problem:</td><td></td><td></td><td></td><td>... | <table><tr><td>Variable</td><td>Dubti</td><td></td><td></td><td>Amibara</td><td></td><td></td><td></td></tr><tr><td></td><td>Female (%)</td><td>Male (%)</td><td>Total (%)</td><td>Female (%)</td><td>male (%)</td><td>Total (%)</td><td>Total (%)</td></tr><tr><td>TBL is a health problem:</td><td></td><td></td><td></td><td>... | <table><tr><td>Variable</td><td>Dubti</td><td></td><td></td><td>Amibara</td><td></td><td></td><td></td></tr><tr><td>Rare</td><td>84 (61.3)</td><td>146 (67.6)</td><td>230 (65.2)*</td><td>133 (76.9)</td><td>168 (77.8)</td><td>301 (77.4)*</td><td>531 (71.6)</td></tr><tr><td>No</td><td>4 (2.9)</td><td>4 (1.9)</td><td>8 (2.... |
6818fb870e7a94459e95223aef22b393550a7251d0a8b5c1cfcf98933cd52a36.png | simple | <table><tr><td></td><td>H1</td><td>Mesendoderm</td><td>Trophoblast-like cells</td><td>Mesenchymal stem cells</td><td>Neuronal progenitor cells</td></tr><tr><td>1</td><td>H3K4me2,H3K4me1, H2aK5ac,H3K27ac, H2bK5ac,H3K23ac, H3K9me3,H3K79me1, H3K4ac,H3K9ac, H2bK120ac</td><td>H3K4me2,H3K4me1, H3K27ac,H3K23ac, H3K9ac,H3K18ac... | <table><tr><td></td><td>H1</td><td>Mesendoderm</td><td>Trophoblast-like cells</td><td>Mesenchymal stem cells</td><td>Neuronal progenitor cells</td></tr><tr><td>1</td><td>H3K4me2,H3K4me1, H2aK5ac,H3K27ac, H2bK5ac,H3K23ac, H3K9me3,H3K79me1, H3K4ac,H3K9ac, H2bK120ac</td><td>H3K4me2,H3K4me1, H3K27ac,H3K23ac, H3K9ac,H3K18ac... | <table><tr><td>8</td><td>H3K4me2,H2aK5ac, H3K27ac,H2bK5ac, H3K27me3,H3K23ac, H3K9me3,H3K79me1, H3K4ac,H3K9ac,H3K18ac</td><td>H3K4me2,H3K4me1, H3K27ac,H3K27me3, H3K4ac,H3K18ac</td><td>H3K4me2,H3K27ac, H3K27me3,H3K23ac, H3K9me3,H3K9ac</td><td>H3K4me2,H3K36me3, H2bK5ac,H3K23ac, H3K4ac,H3K9ac, H2bK120ac</td><td>H3K4me2,H3K... |
583998c164974aa73f9f7901861f89147707d45e085286923cf9b5d75d41bc20.png | simple | <table><tr><td></td><td>Proteins</td><td>Pfam</td><td>SMART</td><td>GO</td><td>Taxonomy</td><td>Semantic similarity</td><td>Functional similarity</td></tr><tr><td>GOTaxExplorer</td><td>b,f,c</td><td>b,f,c</td><td>b,f,c</td><td>b,f,c</td><td>b,f,c</td><td>b,f,-</td><td>b,f,-</td></tr><tr><td>UniProt</td><td>b,f,c</td><t... | <table><tr><td></td></tr><tr><td>GOTaxExplorer</td></tr><tr><td>UniProt</td></tr><tr><td>Pfam</td></tr><tr><td>SMART</td></tr><tr><td>PANTHER*</td></tr><tr><td>InterPro</td></tr><tr><td>BioDW</td></tr><tr><td>GOGraph</td></tr><tr><td>DynGO</td></tr><tr><td>GFSST†</td></tr></table> | <table><tr><td>Proteins</td><td>Pfam</td><td>SMART</td><td>GO</td><td>Taxonomy</td><td>Semantic similarity</td><td>Functional similarity</td></tr><tr><td>b,f,c</td><td>b,f,c</td><td>b,f,c</td><td>b,f,c</td><td>b,f,c</td><td>b,f,-</td><td>b,f,-</td></tr><tr><td>b,f,c</td><td>b,f,c</td><td>b,f,c</td><td>b,f,c</td><td>b,f... |
dfddc0634b3104887c8902e08f0dc8ba298d634b039db4b76dbd5c9cc54408d7.png | simple | <table><tr><td>First author</td><td>Year</td><td>Year of recruitment</td><td>Race</td><td>Stage</td><td>Pathological type</td><td>No. of Patients</td><td>HPV + ve<i>N</i> (%)</td><td>Age, y</td><td>Genotype(s)</td><td>DNA method</td><td>Median follow-up period (months)</td><td>Hazardratio</td></tr><tr><td>Iwamasa</td><... | <table><tr><td>First author</td><td>Year</td><td>Year of recruitment</td><td>Race</td><td>Stage</td><td>Pathological type</td><td>No. of Patients</td><td>HPV + veN (%)</td><td>Age, y</td><td>Genotype(s)</td><td>DNA method</td><td>Median follow-up period (months)</td><td>Hazardratio</td></tr><tr><td>Iwamasa</td><td>2000... | <table><tr><td>Wang</td><td>2014</td><td>2003-2011</td><td>Asian</td><td>I-IV</td><td>LA</td><td>210</td><td>74(35.2)</td><td>69.5</td><td>16,18</td><td>PCR</td><td>12.6</td><td>Report</td></tr></table> |
a0775d09e1dcbf952447ff53cc950f12e4779e10f46f0e06ff3c38500e659031.png | simple | <table><tr><td>Type of Study/Description</td><td>Advantages</td><td>Limitations</td></tr><tr><td>Cell culture – in vitroFood item is placed in cells or other tissues in culture conditions.</td><td>Help determine mechanisms of action.Provide clues for further investigation to define mechanisms responsible for how ... | <table><tr><td>Type of Study/Description</td><td>Advantages</td><td>Limitations</td></tr><tr><td>Cell culture – in vitroFood item is placed in cells or other tissues in culture conditions.</td><td>Help determine mechanisms of action.Provide clues for further investigation to define mechanisms responsible for how food c... | <table><tr><td>Epidemiological/observationalGroups of subjects, typically living in one geographical area, who have developed a disease or condition are compared with a similar sample of subjects who have not developed the disease.</td><td>Address whether a certain food/component could cause a disease but not whether i... |
2e1e540dd80be0ff45b21bd88d5ed5cd13dc534e62e4ac0dbf1b03f9977bb982.png | complex | <table><tr><td> </td><td colspan="5"><i>Reliability</i></td></tr><tr><td>Study characteristics</td><td># of data points K</td><td>Total sample size N</td><td>Sample-weighted mean reliability (SD)</td><td>95nnnnn CI</td><td>PVA<sub>SE</sub></td></tr><tr><td>EDI total</td><td>2</td><td>471</td><td>.81 (.06)</td><td>.72 -... | <table><tr><td></td><td colspan="5">Reliability</td></tr><tr><td>Study character</td><td># of da</td><td>Total sample siz</td><td>Sample-weighted mean relia</td><td>95nnnnn</td><td>PV</td></tr></table> | <table><tr><td>istics</td><td>ta points K</td><td>e N</td><td>bility (SD)</td><td> CI</td><td>ASE</td></tr><tr><td>EDI total</td><td>2</td><td>471</td><td>.81 (.06)</td><td>.72 - .90</td><td>12.68%</td></tr><tr><td>EDI body dissatisfaction subscale</td><td>3</td><td>256</td><td>.77 (.14)</td><td>.62 - .92</td><td>10.66... |
c67b6fcebe4cc77531e461f81cee286cac270671303007ff8d6a104e67c22989.png | simple | <table><tr><td></td><td></td><td></td><td></td><td>p/q<sup>a</sup></td><td>p/q<sup>b</sup></td></tr><tr><td>rs16861210</td><td>GG (224)</td><td>GA (12)</td><td>AA (1)</td><td></td><td></td></tr><tr><td>All</td><td>7.76 (7.32-8.22)</td><td>10.27 (8.29-12.45)</td><td>11.79 (5.33-20.77)</td><td>0.029/0.032</td><td>0.143/0... | <table><tr><td></td><td></td><td></td><td></td><td>p/qa</td><td>p/qb</td></tr><tr><td>rs16861210</td><td>GG (224)</td><td>GA (12)</td><td>AA (1)</td><td></td><td></td></tr></table> | <table><tr><td></td><td></td><td></td><td></td><td>p/qa</td><td>p/qb</td></tr><tr><td>All</td><td>7.76 (7.32-8.22)</td><td>10.27 (8.29-12.45)</td><td>11.79 (5.33-20.77)</td><td>0.029/0.032</td><td>0.143/0.495</td></tr><tr><td></td><td>GG (224)</td><td>AA, AG (13)</td><td></td><td></td><td></td></tr><tr><td>All</td><td>... |
236748c400c79103f5b0149c18f70a0b7ebc8c1114f17982e3d121ecc00a6622.png | simple | <table><tr><td>S. no.</td><td>Inflammatory response/pathologic condition</td><td>Reference</td><td>Treatment dose</td><td>Radiation dose</td><td>Period of course</td><td>Drug type</td></tr><tr><td>1</td><td>Pneumonitis</td><td>(107)</td><td>Adriamycin: 50 mg/m<sup>2</sup> rechallenged for two further cycles with no sym... | <table><tr><td>S. no.</td><td>Inflammatory response/pathologic condition</td><td>Reference</td><td>Treatment dose</td><td>Radiation dose</td><td>Period of course</td><td>Drug type</td></tr><tr><td>1</td><td>Pneumonitis</td><td>(107)</td><td>Adriamycin: 50 mg/m2 rechallenged for two further cycles with no symptoms with ... | <table><tr><td>S. no.</td><td>Inflammatory response/pathologic condition</td><td>Reference</td><td>Treatment dose</td><td>Radiation dose</td><td>Period of course</td><td>Drug type</td></tr><tr><td>7</td><td></td><td>(112)</td><td>Genistein diet (10 mg/kg) (in combination with radiation)</td><td>10 Gy</td><td>9 fraction... |
b744102f83e06053891e42c808e798620d5174f270f45fbb7f6d0064f3bd8ae8.png | complex | <table><tr><td>Factor</td><td>Items</td><td>Responses</td><td>values</td></tr><tr><td colspan="4">Outcome variables</td></tr><tr><td> Latrine ownership</td><td>Ownership of latrine</td><td>No/Yes for ownership of latrine</td><td>0/1</td></tr><tr><td colspan="4"> Consistent latrine use</td></tr><tr><td colspan="4">Predi... | <table><tr><td>Factor</td><td>Items</td><td>Responses</td></tr><tr><td colspan="3">Outcome variables</td></tr><tr><td>Latrine ownership</td><td>Ownership of latrine</td><td>No/Yes for ownership of latrine</td></tr><tr><td colspan="3">Consistent latrine use</td></tr><tr><td colspan="3">Predictor variables</td></tr><tr><... | <table><tr><td>values</td></tr><tr><td>Outcome variables</td></tr><tr><td>0/1</td></tr><tr><td>Consistent latrine use</td></tr><tr><td>Predictor variables</td></tr><tr><td>Risk Perception</td></tr><tr><td>1 to 5</td></tr><tr><td>1 to 5</td></tr><tr><td>Attitude (affective)</td></tr><tr><td>1 to 5</td></tr><tr><td>1 to ... |
5fba015a2f0835e34320dc39684bb4fa0326433b73bc2a3ac9529cb07f3a5050.png | simple | <table><tr><td> </td><td>Cases</td><td>Controls</td><td>Total</td></tr><tr><td>Number of admissions to rehab facility</td><td>n (%)</td><td>n (%)</td><td>n (%)</td></tr><tr><td>0</td><td>27 (84)</td><td>19 (79)</td><td>46 (82)</td></tr><tr><td>1</td><td>3 (9)</td><td>5 (21)</td><td>8 (14)</td></tr><tr><td>2</td><td>1 (... | <table><tr><td></td><td>Cases</td><td>Controls</td><td>Total</td></tr><tr><td>Number of admissions to rehab facility</td><td>n (%)</td><td>n (%)</td><td>n (%)</td></tr><tr><td>0</td><td>27 (84)</td><td>19 (79)</td><td>46 (82)</td></tr><tr><td>1</td><td>3 (9)</td><td>5 (21)</td><td>8 (14)</td></tr><tr><td>2</td><td>1 (3... | <table><tr><td>Total</td><td>32 (100)</td><td>24 (100)</td><td>56 (100)</td></tr></table> |
db43024adfb4f1626c5688105af24f65184b47d0794dd8f919e3e7b913b2de40.png | complex | <table><tr><td>Variable</td><td>Mean</td><td>Median</td><td>Standard deviation</td><td>Relative standard deviation</td></tr><tr><td colspan="5"><i>Child survey</i></td></tr><tr><td>Percentage of overweight and obese pre-school children (5–6 years) (dependent variable)</td><td>9.31</td><td>8.60</td><td>4.19</td><t... | <table><tr><td>Variable</td><td>Mean</td><td>Median</td><td>Standard deviation</td><td>Relative standard deviation</td></tr><tr><td colspan="5">Child survey</td></tr><tr><td>Percentage of overweight and obese pre-school children (5–6 years) (dependent variable)</td><td>9.31</td><td>8.60</td><td>4.19</td><td>45.02</td><... | <table><tr><td>Availability of public transport</td><td>1134.74</td><td>868.42</td><td>914.95</td><td>80.63</td></tr><tr><td colspan="5">Walkability</td></tr><tr><td>Connectivity</td><td>−0.04</td><td>−0.09</td><td>1.00</td><td>−2377.29</td></tr><tr><td>Entropy</td><td>−0.10</td><td>0.03</td><td>1.00</td><td>−1012.31</... |
f93907c2e223bd1290b4b90e912dfee3892e65acfef471ce17b3b409ca3b4495.png | simple | <table><tr><td>Device</td><td>Number of Bits</td><td>Sampling Rate (GSPS) </td></tr><tr><td>Texas Instruments ADC12DJ3200</td><td>12</td><td>6.4</td></tr><tr><td>Texas Instruments ADC32RF45</td><td>14</td><td>3.0</td></tr><tr><td>Texas Instruments ADS54J60</td><td>16</td><td>1.0</td></tr><tr><td>Texas Instruments ADS16... | <table><tr><td>Device</td><td>Number of Bits</td><td>Sampling Rate (GSPS)</td></tr></table> | <table><tr><td>Texas Instruments ADC12DJ3200</td><td>12</td><td>6.4</td></tr><tr><td>Texas Instruments ADC32RF45</td><td>14</td><td>3.0</td></tr><tr><td>Texas Instruments ADS54J60</td><td>16</td><td>1.0</td></tr><tr><td>Texas Instruments ADS1675</td><td>24</td><td>0.004</td></tr></table> |
304261b1a716b4b71a901e6105b40854517acfe37bdd0e854ca26ad8231ded60.png | simple | <table><tr><td></td><td>Value</td></tr><tr><td>Number of patients</td><td>71</td></tr><tr><td>Pathologic lesion, <i>n</i> (%)</td><td></td></tr><tr><td> Yes</td><td>42 (59.2)</td></tr><tr><td> No</td><td>29 (40.8)</td></tr><tr><td>Indication, <i>n</i> (%)</td><td></td></tr><tr><td> Primary staging</td><td>16 (22.5)</td... | <table><tr><td></td><td>Value</td></tr><tr><td>Number of patients</td><td>71</td></tr><tr><td>Pathologic lesion, n (%)</td><td></td></tr><tr><td>Yes</td><td>42 (59.2)</td></tr><tr><td>No</td><td>29 (40.8)</td></tr><tr><td>Indication, n (%)</td><td></td></tr><tr><td>Primary staging</td><td>16 (22.5)</td></tr><tr><td>Fol... | <table><tr><td>ypopharynx, nasopharynx, oropharynx, ovarian, paraganglioma, myeloid sarcoma, mesothelioma, rectal, SCC right upper arm</td><td>1</td></tr><tr><td>Under therapy, n (%)</td><td></td></tr><tr><td>Yes</td><td>13 (18.3)</td></tr><tr><td>No</td><td>56 (78.9)</td></tr><tr><td>N/A</td><td>2 (2.8)</td></tr></tab... |
67eac98bdb62955aaee7e80a182d1ff24af49ad3e1855fdcc3cf1d72597ccc13.png | simple | <table><tr><td>Lipase</td><td>Porcine pancreatic lipase (PPL)</td><td><i>Pseudomonas</i> sp. (PSL)</td><td><i>Pseudomonas fluorescens</i> lipase (Lipase AK, AKL)</td><td><i>Candida cylindracea</i> A.Y. lipase (AYL)</td><td><i>Candida rugosa</i> lipase (CRL)</td><td>Novozyme 435</td></tr><tr><td>Activity (μmol/h/g)... | <table><tr><td>Lipase</td><td>Porcine pancreatic lipase (PPL)</td><td>Pseudomonas sp. (PSL)</td><td>Pseudomonas fluorescens lipase (Lipase AK, AKL)</td><td>Candida cylindracea A.Y. lipase (AYL)</td><td>Candida rugosa lipase (CRL)</td><td>Novozyme 435</td></tr></table> | <table><tr><td>Activity (μmol/h/g)</td><td>2.25</td><td>0.67</td><td>1.32</td><td>0.54</td><td>0.27</td><td>1.47</td></tr></table> |
7678a96f045dcb7038470b92892bb2b8e815bbd7eb3818c5a3be7494fd66e01b.png | simple | <table><tr><td></td><td>S/L<sup>† </sup>group (n = 72)</td><td>R/H<sup>‡ </sup>group (n = 13)</td><td>Total (n = 85)</td><td><i>p</i></td></tr><tr><td></td><td>number (%) *</td><td>number (%) *</td><td>number (%) *</td><td></td></tr><tr><td>EpidemiologicalData</td><td></td><td></td><td></td><td></td></tr><t... | <table><tr><td></td><td>S/L† group (n = 72)</td><td>R/H‡ group (n = 13)</td><td>Total (n = 85)</td><td>p</td></tr><tr><td></td><td>number (%) *</td><td>number (%) *</td><td>number (%) *</td><td></td></tr><tr><td>EpidemiologicalData</td><td></td><td></td><td></td><td></td></tr><tr><td>Sex</td><td></td><td></td><td></td>... | <table><tr><td></td><td>S/L† group (n = 72)</td><td>R/H‡ group (n = 13)</td><td>Total (n = 85)</td><td>p</td></tr><tr><td></td><td>number (%) *</td><td>number (%) *</td><td>number (%) *</td><td></td></tr><tr><td>5</td><td>)</td><td>)</td><td></td><td></td></tr><tr><td>×4</td><td>4 (5.6)</td><td>0 (0)</td><td>4 (4.7)</t... |
da493b77f09f22c5450a92f6d9e2a21104141fc8d783fff8e981b9db14a6f1ca.png | complex | <table><tr><td> </td><td>Bias</td><td colspan="2">Limits of agreement</td><td colspan="2">95%-CI</td><td>p-value</td></tr><tr><td> </td><td> </td><td>Lower</td><td>Upper</td><td>Lower</td><td>Upper</td><td> </td></tr><tr><td>GAT2 (S) – GAT1 (S)</td><td>−0.06</td><td>−1.74</td><td>1.63</td><td>−0... | <table><tr><td></td><td>Bias</td><td colspan="2">Limits of agreement</td><td colspan="2">95%-CI</td><td>p-value</td></tr><tr><td></td><td></td><td>Lower</td><td>Upper</td><td>Lower</td><td>Upper</td><td></td></tr><tr><td>GAT2 (S) – GAT1 (S)</td><td>−0.06</td><td>−1.74</td><td>1.63</td><td>−0.235</td><td>0.347</td><td>0... | <table><tr><td></td><td>Bias</td><td colspan="2">Limits of agreement</td><td colspan="2">95%-CI</td><td>p-value</td></tr><tr><td></td><td></td><td>Lower</td><td>Upper</td><td>Lower</td><td>Upper</td><td></td></tr><tr><td>MICP (R) – MGAT (S)</td><td>1.7</td><td>−2.9</td><td>6.2</td><td>0.864</td><td>2.439</td><td><0.001... |
97f28871fe85baa33d3ed932914c251de8c89f5e71b71278f59ab977155197ef.png | complex | <table><tr><td> </td><td>Percentage<sub>EBP-K</sub></td><td>Percentage<sub>EBP-A</sub></td><td>Percentage<sub>EBP-P</sub></td><td>Percentage<sub>EBP-F</sub></td></tr><tr><td>Total</td><td>19.21 ± 3.2%</td><td>20.83 ± 2.1%</td><td>48.97 ± 8.6%</td><td>17.82 ± 5.7%</td></tr><tr><td>Gender</td><td> </t... | <table><tr><td></td><td>PercentageEBP-K</td><td>PercentageEBP-A</td><td>PercentageEBP-P</td><td>PercentageEBP-F</td></tr></table> | <table><tr><td>Total</td><td>19.21 ± 3.2%</td><td>20.83 ± 2.1%</td><td>48.97 ± 8.6%</td><td>17.82 ± 5.7%</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td></tr><tr><td>Male</td><td>19.23 ± 2.2%</td><td>20.84 ± 2.8%</td><td>48.96 ± 7.9%</td><td>17.83 ± 1.7%</td></tr><tr><td>Female</td><td>19.18 ± 1.8%</td>... |
af6ffc5bafb149de6d545ac779bcc63f4bb25d918752ef6b20e4106af49f1cd0.png | complex | <table><tr><td rowspan="2" colspan="2">Confusion Matrix</td><td colspan="2">Expert Classification</td></tr><tr><td>Positive</td><td>Negative</td></tr><tr><td rowspan="2">Classifier classification</td><td>Positive</td><td>TP = 19,050</td><td>FP = 3772</td></tr><tr><td>Negative</td><td>FN = 950</td><td>TN = 76,228</td></... | <table><tr><td colspan="2">Confusion Matrix</td><td colspan="2">Expert Classification</td></tr></table> | <table><tr><td colspan="2">Confusion Matrix</td><td>Positive</td><td>Negative</td></tr><tr><td rowspan="2">Classifier classification</td><td>Positive</td><td>TP = 19,050</td><td>FP = 3772</td></tr><tr><td>Negative</td><td>FN = 950</td><td>TN = 76,228</td></tr></table> |
fe044bfc04fae10e611ebcb0f6339148c0220cc4ab8895ed90e44b083c7872e1.png | complex | <table><tr><td>Associated risk factors</td><td>BAB</td><td>PAB</td><td>VAB</td></tr><tr><td colspan="4"><underline>Individual factors</underline></td></tr><tr><td>Age (years) 85 and over</td><td></td><td>+</td><td></td></tr><tr><td>Male gender</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Functionally independent</td>... | <table><tr><td>Associated risk factors</td><td>BAB</td><td>PAB</td><td>VAB</td></tr><tr><td colspan="4">Individual factors</td></tr><tr><td>Age (years) 85 and over</td><td></td><td>+</td><td></td></tr><tr><td>Male gender</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Functionally independent</td><td></td><td></td><td>+... | <table><tr><td colspan="4">al factors</td></tr><tr><td>Use of benzodiazepine drugs</td><td></td><td></td><td>+</td></tr><tr><td>Use of neuroleptic drugs</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Use of physical restraints</td><td>+</td><td></td><td></td></tr></table> |
5c52410451d9acc534b8be1825e8480f7cb68a60129b653a13c725e87de308b1.png | simple | <table><tr><td></td><td>Increase</td><td>Decrease</td><td>No response</td><td>Total</td></tr><tr><td>Normal</td><td>11 (58%)</td><td>5 (26%)</td><td>3 (16%)</td><td>19 (100%)</td></tr><tr><td>Lesioned</td><td>19 (68%)</td><td>4 (14%)</td><td>5 (18%)</td><td>28 (100%)</td></tr></table> | <table><tr><td></td></tr><tr><td>Normal</td></tr><tr><td>Lesioned</td></tr></table> | <table><tr><td>Increase</td><td>Decrease</td><td>No response</td><td>Total</td></tr><tr><td>11 (58%)</td><td>5 (26%)</td><td>3 (16%)</td><td>19 (100%)</td></tr><tr><td>19 (68%)</td><td>4 (14%)</td><td>5 (18%)</td><td>28 (100%)</td></tr></table> |
b7e0af7725b4665602b1e50aaec1a8a0ced4a67d790de023023030efe127141a.png | simple | <table><tr><td></td><td>N</td><td>Yes (%)</td></tr><tr><td>“Access to his/her diabetes EMR via a web portal ...”</td><td>128</td><td></td></tr><tr><td> stimulates the self-management and self-correcting behaviour of the patient</td><td></td><td>75.8</td></tr><tr><td> improves communication during consultati... | <table><tr><td></td><td>N</td><td>Yes (%)</td></tr><tr><td>“Access to his/her diabetes EMR via a web portal ...”</td><td>128</td><td></td></tr><tr><td>stimulates the self-management and self-correcting behaviour of the patient</td><td></td><td>75.8</td></tr><tr><td>improves communication during consultation with a well... | <table><tr><td>the nurse (nurse practitioner or diabetes nurse) answers all messages</td><td>66.3</td></tr></table> |
6b667b854b29f727170959a97a184a6ae0b70e5fe1e6d595a10668dfdc60af49.png | simple | <table><tr><td></td><td>Hazard ratio for in-hospital death</td><td>95% CI</td><td>p value</td><td>Hazard ratio for death within 1 year</td><td>95% CI</td><td>p value</td></tr><tr><td>Age</td><td></td><td></td><td>0.068</td><td></td><td></td><td>0.005</td></tr><tr><td> 18–64 years</td><td>1</td><td></td><td></td><... | <table><tr><td></td><td>Hazard ratio for in-hospital death</td><td>95% CI</td><td>p value</td><td>Hazard ratio for death within 1 year</td><td>95% CI</td><td>p value</td></tr><tr><td>Age</td><td></td><td></td><td>0.068</td><td></td><td></td><td>0.005</td></tr><tr><td>18–64 years</td><td>1</td><td></td><td></td><td>1</t... | <table><tr><td></td><td>Hazard ratio for in-hospital death</td><td>95% CI</td><td>p value</td><td>Hazard ratio for death within 1 year</td><td>95% CI</td><td>p value</td></tr><tr><td>Tricuspid</td><td>1.04</td><td>0.22–4.88</td><td></td><td>0.73</td><td>0.16–3.35</td><td></td></tr><tr><td>Two native valves</td><td>3.55... |
4696c0ecb9a03254ff00cc742e001eb0bd5743fbc788e36d36637cbb7caac8e0.png | complex | <table><tr><td>Socio-demographic characteristics</td><td>Frequency</td><td>Percentage</td></tr><tr><td colspan="3">LGA</td></tr><tr><td> Idemili South</td><td>70</td><td>46.4</td></tr><tr><td> Onitsha South</td><td>81</td><td>53.6</td></tr><tr><td colspan="3">Groups</td></tr><tr><td> Mothers of women who delivered 6 mo... | <table><tr><td>Socio-demographic characteristics</td><td>Frequency</td><td>Percentage</td></tr><tr><td colspan="3">LGA</td></tr><tr><td>Idemili South</td><td>70</td><td>46.4</td></tr><tr><td>Onitsha South</td><td>81</td><td>53.6</td></tr><tr><td colspan="3">Groups</td></tr><tr><td>Mothers of women who delivered 6 month... | <table><tr><td>Married</td><td>147</td><td>97.4</td></tr><tr><td>Widowed</td><td>4</td><td>2.6</td></tr><tr><td colspan="3">Educational level</td></tr><tr><td>No formal education</td><td>6</td><td>4</td></tr><tr><td>Primary</td><td>55</td><td>36.4</td></tr><tr><td>Secondary</td><td>75</td><td>49.7</td></tr><tr><td>Post... |
e8e1b93df04f2238bdc278f5c88afdbd5fc0186111a2fcdeebbfd867d0378686.png | complex | <table><tr><td rowspan="2">Variables</td><td>LVEF ≤ 25%</td><td>LVEF > 25%</td><td rowspan="2"><i>P</i> values</td></tr><tr><td>115 patients</td><td>821 patients</td></tr><tr><td>Braden score</td><td>14.4 ± 2.6</td><td>14.8 ± 2.6</td><td>0.121</td></tr><tr><td>Total Glasgow coma score</td><td>12.1 &#... | <table><tr><td rowspan="2">Variables</td><td>LVEF ≤ 25%</td></tr><tr><td>115 patients</td></tr><tr><td>Braden score</td><td>14.4 ± 2.6</td></tr><tr><td>Total Glasgow coma score</td><td>12.1 ± 3.9</td></tr><tr><td>Heart rate (beats/minute)</td><td>88.6 ± 17.8</td></tr><tr><td>Diastolic NBP (mmHg)</td><td>59.2 ± 12.0</td... | <table><tr><td>LVEF > 25%</td><td rowspan="2">P values</td></tr><tr><td>821 patients</td></tr><tr><td>14.8 ± 2.6</td><td>0.121</td></tr><tr><td>12.5 ± 3.6</td><td>0.345</td></tr><tr><td>84.2 ± 19.2</td><td>0.021</td></tr><tr><td>60.8 ± 13.6</td><td>0.249</td></tr><tr><td>120.1 ± 20.2</td><td><0.001</td></tr><tr><td>19.... |
06839781a09e07e1023846a316ec5fa8c695404f4e62298e92578bb4d8b06408.png | simple | <table><tr><td>Compound</td><td>Catechol</td><td>Phenol</td><td>Total</td></tr><tr><td>Yield [% w/w]</td><td>5.7 ± 0.1</td><td>3.9 ± 0.1</td><td>9.6 ± 0.3</td></tr><tr><td>Content (mM)</td><td>101</td><td>25</td><td>126</td></tr></table> | <table><tr><td>Compound</td><td>Catechol</td><td>Phenol</td><td>Total</td></tr><tr><td>Yield [% w/w]</td><td>5.</td><td></td><td>9.</td></tr></table> | <table><tr><td></td><td>7 ± 0.1</td><td>3.9 ± 0.1</td><td>6 ± 0.3</td></tr><tr><td>Content (mM)</td><td>101</td><td>25</td><td>126</td></tr></table> |
484212df70bf6a176cc2f21821e0de384b858ea2388378cf7b6da85f20b3870f.png | complex | <table><tr><td>SUV</td><td>Myocardium</td><td>Muscle</td></tr><tr><td colspan="3">SUV 7.5 min p.i.</td></tr><tr><td>TGwt</td><td>9.6 ± 2.2</td><td>0.5 ± 0.1</td></tr><tr><td>TGwt insulin</td><td>16.9 ± 2.8*</td><td>0.8 ± 0.2*</td></tr><tr><td>TGmut</td><td>5.8 ± 1.6**</td><td>0.7 ± 0.1</td... | <table><tr><td>SUV</td><td>Myocardium</td><td>Muscle</td></tr><tr><td colspan="3">SUV 7.5 min p.i.</td></tr><tr><td>TGwt</td><td>9.6 ± 2.2</td><td>0.5 ± 0.1</td></tr></table> | <table><tr><td>TGwt insulin</td><td>16.9 ± 2.8*</td><td>0.8 ± 0.2*</td></tr><tr><td>TGmut</td><td>5.8 ± 1.6**</td><td>0.7 ± 0.1</td></tr><tr><td>TGmut insulin</td><td>6.4 ± 1.4</td><td>1.1 ± 0.5*</td></tr><tr><td colspan="3">SUV 60 min p.i.</td></tr><tr><td>TGwt</td><td>20.4 ± 3.3</td><td>0.7 ± 0.2</td></tr><tr><td>TGw... |
0b644d22bdd765f7709f5a8ab316323ba44897fdc94b88ace869e17f0aa399b5.png | complex | <table><tr><td>Gene</td><td>OMIM accession number</td><td>SNP</td><td>Ancestral alleles</td><td>Type</td><td>MAF</td><td>p-value</td><td>p-value adjusted</td><td>Beta</td><td>SE</td><td>Trait</td></tr><tr><td rowspan="2"><i>AGTR 1</i></td><td rowspan="2">*106165</td><td rowspan="2">rs5186</td><td rowspan="2">A</td><td ... | <table><tr><td>Gene</td><td>OMIM accession number</td><td>SNP</td><td>Ancestral alleles</td><td>Type</td><td>MAF</td><td>p-value</td><td>p-value adjusted</td><td>Beta</td><td>SE</td><td>Trait</td></tr><tr><td rowspan="2">AGTR 1</td><td rowspan="2">*106165</td><td rowspan="2">rs5186</td><td rowspan="2">A</td><td rowspan... | <table><tr><td>LPL</td><td>609708</td><td>rs1800590</td><td>G</td><td>5’UTR</td><td>2.586</td><td>3.46×10-04</td><td>0.028</td><td>0.076</td><td>0.088</td><td>SBP</td></tr><tr><td rowspan="2">TGFB1</td><td rowspan="2">*190180</td><td rowspan="2">rs1800469</td><td rowspan="2">C</td><td rowspan="2">Upstream</td><td rowsp... |
0e0600de91b572780d631a90b75e7512ede9fc49ebc2192a8b3ec040402d5d90.png | simple | <table><tr><td></td><td>Baseline</td><td>1 month</td><td>3 months</td><td>6 months</td><td>12 months</td></tr><tr><td>S100A12</td><td>0.78***/0.75***</td><td>0.68***/0.65***</td><td>0.35/0.27</td><td>0.55*/0.45*</td><td>0.43/0.43</td></tr><tr><td>ESR</td><td>0.37/0.48*</td><td>0.36/0.35</td><td>0.45*/0.42</td><td>0.32/... | <table><tr><td></td><td>Baseline</td><td>1 month</td><td>3 months</td><td>6 months</td><td>12 months</td></tr><tr><td>S100A12</td><td>0.78***/0.75***</td><td>0.68***/0.65***</td><td>0.35/0.27</td><td>0.55*/0.45*</td><td>0.43/0.43</td></tr><tr><td>ESR</td><td>0.37/0.48*</td><td>0.36/0.35</td><td>0.45*/0.42</td><td>0.32/... | <table><tr><td>CRP</td><td>0.33/0.34</td><td>0.04/0.11</td><td>0.49*/0.35</td><td>0.59**/0.43</td><td>0.57**/0.55*</td></tr></table> |
a1454ad859d06946ea00fe44f14ed9869ec7826a882a4d0b6b590abb77ef5d74.png | complex | <table><tr><td></td><td colspan="5">CHILD</td></tr><tr><td>Educational level</td><td>Underweight(%)</td><td>Normalweight(%)</td><td>Overweight(%)</td><td>Obese(%)</td><td>TotalNo. (%)</td></tr><tr><td>MOTHER</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> <i>Low</i></td><td>0.8</td><td>69.1</td><td>20.8<... | <table><tr><td></td><td colspan="5">CHILD</td></tr></table> | <table><tr><td>Educational level</td><td>Underweight(%)</td><td>Normalweight(%)</td><td>Overweight(%)</td><td>Obese(%)</td><td>TotalNo. (%)</td></tr><tr><td>MOTHER</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Low</td><td>0.8</td><td>69.1</td><td>20.8</td><td>9.3</td><td>534 (100)</td></tr><tr><td>Mediu... |
913890611ebcfc6991291c5b3a00c0381e4b4f31e798be819924b5b025dff983.png | complex | <table><tr><td rowspan="2">Patient no.</td><td colspan="2">FOXP3</td><td colspan="2">OX40</td><td colspan="2">CD123</td><td colspan="2">DC-LAMP</td></tr><tr><td>SLN</td><td>NSLN</td><td>SLN</td><td>NSLN</td><td>SLN</td><td>NSLN</td><td>SLN</td><td>NSLN</td></tr><tr><td>1</td><td>1958</td><td>957</td><td>193</td><td>65<... | <table><tr><td rowspan="2">Patient no.</td><td colspan="2">FOXP3</td><td colspan="2">OX40</td><td colspan="2">CD123</td><td colspan="2">DC-LAMP</td></tr><tr><td>SLN</td><td>NSLN</td><td>SLN</td><td>NSLN</td><td>SLN</td><td>NSLN</td><td>SLN</td><td>NSLN</td></tr><tr><td>1</td><td>1958</td><td>957</td><td>193</td><td>65<... | <table><tr><td>2</td><td>1925</td><td>1477</td><td>119</td><td>192</td><td>1450</td><td>621</td><td>957</td><td>648</td></tr><tr><td>3</td><td>2205</td><td>1060</td><td>15</td><td>60</td><td>222</td><td>214</td><td>573</td><td>1038</td></tr><tr><td>4</td><td>1562</td><td>1450</td><td>117</td><td>29</td><td>938</td><td>... |
a11234a1bc234f5282010ce4f0cd2d59bd662514445c34fa93c81b3c8f922e1b.png | simple | <table><tr><td></td><td>Sham (<i>n</i> = 6)</td><td>2nd PO week (<i>n</i> = 3)</td><td>4th PO week (<i>n</i> = 4)</td><td>6th PO week (<i>n</i> = 5)</td></tr><tr><td>Albumin (g/dL)</td><td>2.5 ± 0</td><td>BDL: 2.4 ± 0.37BDL + AM: 2.85 ± 0.07</td><td>BDL: 1.88 ± 0.5<sup>∗</sup>BDL + AM: 2.9 ... | <table><tr><td></td><td>Sham (n = 6)</td><td>2nd PO week (n = 3)</td><td>4th PO week (n = 4)</td><td>6th PO week (n = 5)</td></tr><tr><td>Albumin (g/dL)</td><td>2.5 ± 0</td><td>BDL: 2.4 ± 0.37BDL + AM: 2.85 ± 0.07</td><td>BDL: 1.88 ± 0.5∗BDL + AM: 2.9 ± 0†</td><td>BDL: 1.99 ± 0.17BDL + AM: 3.33 ± 0.36‡†</td></tr><tr><t... | <table><tr><td>ase (U/L)</td><td>± 99</td><td> 84BDL + AM: 324 ± 0</td><td>5.6 ± 197.53BDL + AM: 419 ± 56.57</td><td>278 ± 171</td></tr><tr><td>GGT (U/L)</td><td>0 ± 0</td><td>BDL: 24.75 ± 28.93BDL + AM: 79 ± 0</td><td>BDL: 35.8 ± 21.29BDL + AM: 13.5 ± 19.09</td><td>BDL: 33 ± 27.4BDL + AM: 1.86 ± 3.49††</td></tr><tr><t... |
58befc6cca7d66b96d1c91cc8495a2cb44d41792b8be54e1b13219cb65bb07fc.png | simple | <table><tr><td>Item</td><td>Points</td><td>Definition</td></tr><tr><td>Pain</td><td>25</td><td>No pain</td></tr><tr><td></td><td>20</td><td>Mild, occasional</td></tr><tr><td></td><td>15</td><td>Moderate (tolerable)</td></tr><tr><td></td><td>0</td><td>Severe, intolerable</td></tr><tr><td>Return to sport (work) at 6 mont... | <table><tr><td>Item</td><td>Points</td></tr><tr><td>Pain</td><td>25</td></tr><tr><td></td><td>20</td></tr><tr><td></td><td>15</td></tr><tr><td></td><td>0</td></tr><tr><td>Return to sport (work) at 6 months</td><td>25</td></tr><tr><td></td><td>20</td></tr><tr><td></td><td>15</td></tr><tr><td></td><td>0</td></tr><tr><td>... | <table><tr><td>Definition</td></tr><tr><td>No pain</td></tr><tr><td>Mild, occasional</td></tr><tr><td>Moderate (tolerable)</td></tr><tr><td>Severe, intolerable</td></tr><tr><td>Return without protection</td></tr><tr><td>Return with protection</td></tr><tr><td>Restricted return to sport, only exercises</td></tr><tr><td>... |
6831e0b6edd533fbb0ab491c0026da57fa9c5c1706730f9d11358fd68938a2da.png | complex | <table><tr><td rowspan="3">Test</td><td colspan="10">Channel</td><td rowspan="3">Average</td></tr><tr><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td></tr><tr><td>A</td><td>0.240</td><td>0.423</td><td>0.325</td><td>0.726</td><td>0.681</td><td>0.682</td><td>0.701</td>... | <table><tr><td rowspan="3">Test</td><td colspan="10">Channel</td><td rowspan="3">Average</td></tr><tr><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td></tr><tr><td colspan="10"></td></tr><tr><td>A</td><td>0.</td><td>0.42</td><td>0.</td><td>0</td><td></td><td>0.68</td>... | <table><tr><td></td><td>240</td><td>3</td><td>325</td><td>.726</td><td>0.681</td><td>2</td><td>0.701</td><td>0.663</td><td>681</td><td></td><td>37</td></tr><tr><td>B</td><td>0.548</td><td>0.697</td><td>0.307</td><td>0.612</td><td>0.537</td><td>0.429</td><td>0.629</td><td>0.711</td><td>0.715</td><td>0.618</td><td>0.580<... |
02ec9135410c643f6518fb654437dfe6ab8a099963a2d197c0640d1d864707e9.png | simple | <table><tr><td> </td><td>Infants (younger than or equal to 1-year old)</td><td>Older patients (older than 1-year old)</td><td><i>P</i> value</td></tr><tr><td>Number of cases</td><td>18</td><td>108</td><td> </td></tr><tr><td>Gender (M/F)</td><td>10/8</td><td>72/36</td><td> </td></tr><tr><td>Age range (median)</td><td>0.... | <table><tr><td></td><td>Infants (younger than or equal to 1-year old)</td><td>Older patients (older than 1-year old)</td><td>P value</td></tr><tr><td>Number of cases</td><td>18</td><td>108</td><td></td></tr><tr><td>Gender (M/F)</td><td>10/8</td><td>72/36</td><td></td></tr><tr><td>Age range (median)</td><td>0.66</td><td... | <table><tr><td></td><td>Infants (younger than or equal to 1-year old)</td><td>Older patients (older than 1-year old)</td><td>P value</td></tr><tr><td>isk (%)</td><td></td><td></td><td>0.64</td></tr><tr><td>Low</td><td>22.2</td><td>15.7</td><td></td></tr><tr><td>Intermediate</td><td>66.7</td><td>65.7</td><td></td></tr><... |
3c0147343e331ecd8bea2c8d9ce03256e263a348363ec1ece5b20c68603c642a.png | complex | <table><tr><td rowspan="2">Reexposure Test Result</td><td colspan="2">Hepatocellular Injury</td><td colspan="2">Cholestatic or Mixed Liver Injury</td></tr><tr><td>ALTb</td><td>ALTr</td><td>ALPb</td><td>ALPr</td></tr><tr><td>●Positive</td><td><5N</td><td>≥2ALTb</td><td><2N</td><td>≥2ALPb</td></tr... | <table><tr><td rowspan="2">Reexposure Test Result</td><td colspan="2">Hepatocellular Injury</td><td colspan="2">Cholestatic or Mixed Liver Injury</td></tr><tr><td>ALTb</td><td>ALTr</td><td>ALPb</td><td>ALPr</td></tr><tr><td>●Positive</td><td><5N</td><td>≥2ALTb</td><td><2N</td><td>≥2ALPb</td></tr><tr><td>●Negative</td><... | <table><tr><td>ive</td><td>≥5N</td><td><2ALTb</td><td>2N</td><td>2ALPb</td></tr><tr><td>●Uninterpretable</td><td><5N</td><td>n.a.</td><td><2N</td><td>n.a.</td></tr><tr><td>●Uninterpretable</td><td>n.a.</td><td>≥2ALTb</td><td>n.a.</td><td>≥2ALPb</td></tr><tr><td>●Uninterpretable</td><td>n.a.</td><td>n.a.</td><td>n.a.</t... |
97f65c84ab34215bb01f2da05acc18b40db673a354df4477c92f07adebaae17c.png | complex | <table><tr><td>Ancestry</td><td>Replicate</td><td colspan="2">Descendants of Affected (DA)</td><td colspan="2">Markov blanket of Affected (MBA)</td><td colspan="2">Children of Affected (DA ∩ MBA)</td></tr><tr><td></td><td></td><td>Number of causal SNPs/number of SNPs</td><td><i>P</i>(<i>X</i> ≥ <i>k</i>)</t... | <table><tr><td>Ancestry</td><td>Replicate</td></tr><tr><td></td><td></td></tr><tr><td>Asian</td><td>1–10</td></tr><tr><td></td><td>11–20</td></tr><tr><td></td><td>1–20</td></tr><tr><td></td><td>21–40</td></tr><tr><td></td><td>1</td></tr><tr><td></td><td>2</td></tr><tr><td></td><td>3</td></tr><tr><td></td><td>4</td></tr... | <table><tr><td colspan="2">Descendants of Affected (DA)</td><td colspan="2">Markov blanket of Affected (MBA)</td><td colspan="2">Children of Affected (DA ∩ MBA)</td></tr><tr><td>Number of causal SNPs/number of SNPs</td><td>P(X ≥ k)</td><td>Number of causal SNPs/number of SNPs</td><td>P(X ≥ k)</td><td>Number of causal S... |
131a9263906960e5625dd454371f9232a3eb18b6a2e6451ff9bd266c3140a9f7.png | simple | <table><tr><td>Decades</td><td># cites</td><td>Paper</td><td>Domain</td><td>Institution</td><td>Country</td></tr><tr><td>1945 to 1954</td><td>-</td><td>All cited articles only cited once</td><td>-</td><td>-</td><td>-</td></tr><tr><td>1955 to 1964</td><td>9</td><td>Wilkening, E. A. (1952, May). 'Acceptance of improved f... | <table><tr><td>Decades</td><td># cites</td><td>Paper</td><td>Domain</td><td>Institution</td><td>Country</td></tr><tr><td>1945 to 1954</td><td>-</td><td>All cited articles only cited once</td><td>-</td><td>-</td><td>-</td></tr><tr><td>195</td><td>9</td><td>Wilkening, E. A. (1952, May</td><td>Diffusion of</td><td>Univers... | <table><tr><td>5 to 1964</td><td></td><td>). 'Acceptance of improved farm practices in three coastal plains countries.' Technical Bulletin 98. North Carolina Agricultural Experiment Station.</td><td> innovation</td><td>o</td><td>USA</td></tr><tr><td>1965 to 1974</td><td>36</td><td>Rogers, E.M. (1962). Diffusion of Inno... |
c353a1963377d8bd99cd632421bb40c6dcd68e49420bbfff15911a6af8d15812.png | complex | <table><tr><td colspan="2">Characteristics</td><td>Death during treatmentN (%)</td><td>Alive throughout treatmentN (%)</td><td>p value</td></tr><tr><td colspan="2">N</td><td>37</td><td>528</td><td></td></tr><tr><td colspan="2">Mean age at diagnosis ± SD</td><td>45.0 ± 16.2</td><td>40.7 ± 13.5</td><td>0.0... | <table><tr><td colspan="2">Characteristics</td><td>Death during treatmentN (%)</td><td>Alive throughout treatmentN (%)</td><td>p value</td></tr><tr><td colspan="2">N</td><td>37</td><td>528</td><td></td></tr><tr><td colspan="2">Mean age at diagnosis ± SD</td><td>45.0 ± 16.2</td><td>40.7 ± 13.5</td><td>0.03</td></tr><tr>... | <table><tr><td colspan="2">Median duration of inadequate treatment (days) (IQR) (n = 153)</td><td>23 (6-35)</td><td>18 (9-34)</td><td>0.18</td></tr><tr><td colspan="2">During continuation phase4</td><td>10/33 (30.3)</td><td>116/523 (22.2)</td><td>0.44</td></tr><tr><td colspan="2">Median duration of inadequate treatment... |
4daa7fb7117986621ba1bc341b2f6aef18940db9e61612f8290085962d6aa83d.png | complex | <table><tr><td colspan="2">Variable</td><td>Alive</td><td>Dead of Disease</td><td>Dead other Causes</td><td>p-value</td></tr><tr><td colspan="2">Surgical Approach, n (%)</td><td></td><td></td><td></td><td><0.0001</td></tr><tr><td></td><td>Adrenalectomy</td><td>374 (88.6)</td><td>437 (63.8)</td><td>111 (67.7)</td><td... | <table><tr><td colspan="2">Variable</td><td>Alive</td><td>Dead of Disease</td><td>Dead other Causes</td><td>p-value</td></tr><tr><td colspan="2">Surgical Approach, n (%)</td><td></td><td></td><td></td><td><0.0001</td></tr><tr><td></td><td>Adrenalectomy</td><td>374 (88.6)</td><td>437 (63.8)</td><td>111 (67.7)</td><td></... | <table><tr><td colspan="2">Laterality, n (%)</td><td></td><td></td><td></td><td>0.08</td></tr><tr><td></td><td>Left</td><td>222 (52.6)</td><td>347 (50.7)</td><td>96 (58.5)</td><td></td></tr><tr><td></td><td>Right</td><td>190 (45.0)</td><td>300 (43.8)</td><td>61 (37.2)</td><td></td></tr><tr><td></td><td>Bilateral</td><t... |
3024ee6c7c8540be87349725cc2eec4fd7ebd27688e12e8037ca5905d4555549.png | simple | <table><tr><td></td><td><i>n</i> (%)</td><td>Positive CAPs</td><td>Positive SPTs</td><td><i>n</i> (%)</td><td><i>n</i> (%)</td></tr><tr><td>Distribution of food allergies</td><td>All patients (<i>n</i> = 496)</td><td>N (min‐max, median) (<i>n</i> = 496)</td><td>N (range wheal, median) (<i>n</i> = 496)</td><td>Mue... | <table><tr><td></td><td>n (%)</td><td>Positive CAPs</td><td>Positive SPTs</td><td>n (%)</td><td>n (%)</td></tr><tr><td>Distribution of food allergies</td><td>All patients (n = 496)</td><td>N (min‐max, median) (n = 496)</td><td>N (range wheal, median) (n = 496)</td><td>Mueller 0–2 (n = 238)</td><td>Mueller 3–4 (n = 258)... | <table><tr><td></td><td>n (%)</td><td>Positive CAPs</td><td>Positive SPTs</td><td>n (%)</td><td>n (%)</td></tr><tr><td>Distribution of food allergies</td><td>All patients (n = 496)</td><td>N (min‐max, median) (n = 496)</td><td>N (range wheal, median) (n = 496)</td><td>Mueller 0–2 (n = 238)</td><td>Mueller 3–4 (n = 258)... |
a58dcb29f343830f11a053736e01073d5ba4af6ad9293b024e30efec80e28e4d.png | simple | <table><tr><td>AQP4 Isoforms</td><td>Cell Type</td><td>Intracellular Localization</td><td>Reference</td></tr><tr><td>AQP4a (M1)</td><td>Astrocytes</td><td>PM</td><td>[85,90,95]</td></tr><tr><td>AQP4c (M23)</td><td>Astrocytes, skeletal muscle, kidney</td><td>PM</td><td>[85,90,95]</td></tr><tr><td>AQP4e (Mz)</td><td>Astr... | <table><tr><td>AQP4 Isoforms</td><td>Cell Type</td><td>Intracellular Localization</td><td>Reference</td></tr><tr><td>AQP4a (M1)</td><td>Astrocytes</td><td>PM</td><td>[85,90,95]</td></tr><tr><td>AQP4c (M23)</td><td>Astrocytes, skeletal muscle, kidney</td><td>PM</td><td>[85,90,95]</td></tr><tr><td>A</td><td>Astrocytes (r... | <table><tr><td>QP4e (Mz)</td><td>at), organ of Corti (rat)</td><td>llular vesicles, GA, EC</td><td>[72,89,96]</td></tr><tr><td>AQP4b</td><td>Astrocytes (rat)</td><td>GA</td><td>[89]</td></tr><tr><td>AQP4d</td><td>Astrocytes (rat)</td><td>GA, EC</td><td>[72,89]</td></tr><tr><td>AQP4f</td><td>Astrocytes (rat)</td><td>GA<... |
01080342c9f9b6d89d6ece9e8ea4f7ba3e4a67c9668c91d8726cd13014202ea3.png | simple | <table><tr><td>Site</td><td>Invoiced dollar (US$)</td><td>Matching dollar (US$)</td><td>Donated time dollar (US$)</td><td>Total additional investment (US$)</td><td>Ranking<sup>a</sup></td><td>Degree of change</td></tr><tr><td>Site 1</td><td>1.00</td><td>2.91</td><td>2.33</td><td>5.24</td><td>2</td><td>H</td></tr><tr><t... | <table><tr><td>Site</td><td>Invoiced dollar (US$)</td><td>Matching dollar (US$)</td></tr><tr><td>Site 1</td><td>1.00</td><td>2.91</td></tr><tr><td>Site 2</td><td>1.00</td><td>3.05</td></tr><tr><td>Site 3</td><td>1.00</td><td>1.81</td></tr><tr><td>Site 4</td><td>1.00</td><td>0.84</td></tr><tr><td>Site 5</td><td>1.00</td... | <table><tr><td>Donated time dollar (US$)</td><td>Total additional investment (US$)</td><td>Rankinga</td><td>Degree of change</td></tr><tr><td>2.33</td><td>5.24</td><td>2</td><td>H</td></tr><tr><td>0.52</td><td>3.57</td><td>5</td><td>H</td></tr><tr><td>1.10</td><td>2.91</td><td>7</td><td>L</td></tr><tr><td>0.04</td><td>... |
b970f7ebcaaa703c13b76be5539dc6f15a6a6410a7ae0ee1317e6043ef545ae3.png | simple | <table><tr><td>Year and season</td><td>Mean</td><td>Lower limit (2.50%)</td><td>Median</td><td>Upper limit (97.50%)</td></tr><tr><td><i>2001 - Rainy/Summ</i>er</td><td>0.2286</td><td>0.009099</td><td>0.1516</td><td>0.6998</td></tr><tr><td>2001 - Dry/Winter</td><td>0.7513</td><td>9.63E-04</td><td>0.2329</td><td>5.646</t... | <table><tr><td>Year and season</td><td>Mean</td><td>Lower limit (2.50%)</td><td>Median</td><td>Upper limit (97.50%)</td></tr><tr><td>2001 - Rainy/Summer</td><td>0.2286</td><td>0.009099</td><td>0.1516</td><td>0.6998</td></tr><tr><td>2001 - Dry/Winter</td><td>0.7513</td><td>9.63E-04</td><td>0.2329</td><td>5.646</td></tr>... | <table><tr><td>Year and season</td><td>Mean</td><td>Lower limit (2.50%)</td><td>Median</td><td>Upper limit (97.50%)</td></tr><tr><td>2002 - Rainy/Summer</td><td>.03168</td><td>83-E-04</td><td>3</td><td>307</td></tr><tr><td>2002 - Dry/Winter</td><td>0.7903</td><td>0.08158</td><td>0.487</td><td>3.028</td></tr></table> |
2c2c213c99487c1f52c566430a6d7b738d426613995ff85db3f8fdc562895320.png | simple | <table><tr><td>Risk Factors</td><td>No. HHV8 Infection/No. Tested (%)</td><td>aORs (95%CI) *</td><td><i>p</i>-values</td></tr><tr><td>Ever injected drugs</td><td></td><td></td><td></td></tr><tr><td>No</td><td>21/145 (14.5)</td><td>1.00</td><td></td></tr><tr><td>Yes</td><td>56/296 (18.9)</td><td>1.50 (0.83–2.69)</... | <table><tr><td>Risk Factors</td></tr><tr><td>Ever injected drugs</td></tr><tr><td>No</td></tr><tr><td>Yes</td></tr><tr><td>Ever sharing syringe</td></tr><tr><td>No</td></tr><tr><td>Yes</td></tr><tr><td>Steady partner</td></tr><tr><td>No</td></tr><tr><td>Yes</td></tr><tr><td>Ever had sex in the past month</td></tr><tr><... | <table><tr><td>No. HHV8 Infection/No. Tested (%)</td><td>aORs (95%CI) *</td><td>p-values</td></tr><tr><td></td><td></td><td></td></tr><tr><td>21/145 (14.5)</td><td>1.00</td><td></td></tr><tr><td>56/296 (18.9)</td><td>1.50 (0.83–2.69)</td><td>0.181</td></tr><tr><td></td><td></td><td></td></tr><tr><td>75/430 (17.4)</td><... |
b83a71e7f03c1cc9dc61769cc106498b27e9dfad7fefbe29bc2f4a2b3700a71a.png | complex | <table><tr><td></td><td colspan="3">Prakasam district</td><td colspan="3">Azamgarh district</td></tr><tr><td></td><td>Sex worker</td><td>Casual unpaid partner</td><td>Any partner<sup>#</sup></td><td>Sex worker</td><td>Casual unpaid partner</td><td>Any partner<sup>#</sup></td></tr><tr><td></td><td>%</td><td>%</td><td>%<... | <table><tr><td></td><td colspan="3">Prakasam district</td><td colspan="3">Azamgarh district</td></tr></table> | <table><tr><td></td><td>Sex worker</td><td>Casual unpaid partner</td><td>Any partner#</td><td>Sex worker</td><td>Casual unpaid partner</td><td>Any partner#</td></tr><tr><td></td><td>%</td><td>%</td><td>%</td><td>%</td><td>%</td><td>%</td></tr><tr><td>Total sample size</td><td>633</td><td>633</td><td>633</td><td>639</td... |
6349d836717b33b7626b93e3ec63f9626582e0c98ac8521bee9e06fe0fda8e98.png | simple | <table><tr><td>Calcination temperature (°C)</td><td>Time (min)</td><td>Sheet resistance (mΩ/□)</td></tr><tr><td>400</td><td>30</td><td>7.4</td></tr><tr><td>350</td><td>30</td><td>27.2</td></tr><tr><td>300</td><td>30</td><td>41.3</td></tr><tr><td>300</td><td>60</td><td>40.6</td></tr><tr><td>250</td><td>3... | <table><tr><td>Calcination temperature (°C)</td><td>Time (min)</td><td>Sheet resistance (mΩ/□)</td></tr><tr><td>400</td><td>30</td><td>7.4</td></tr><tr><td>350</td><td>30</td><td>27.2</td></tr><tr><td>300</td><td>30</td><td>41.3</td></tr><tr><td>300</td><td>60</td><td>40.6</td></tr></table> | <table><tr><td>250</td><td>30</td><td>47.6</td></tr><tr><td>250</td><td>60</td><td>45.4</td></tr><tr><td>200</td><td>30</td><td>–</td></tr><tr><td>Non-calcination</td><td>0</td><td>–</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.